JP5328170B2 - Method for producing acetylthiopyrrolidine derivatives - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide an intermediate synthesizing step using non or a reduced amount of a halogen-containing solvent and/or avoiding or decreasing extremely high temperatures and/or low temperatures, in a method for synthesizing a pyrrolidylthiocarbapenem derivative, or to provide a method for producing a pyrrolidylthiocarbapenem derivative using the intermediate synthesizing step. <P>SOLUTION: A method for synthesizing a sulfamide comprises following steps: (a) a step of reacting a halogenated sulfonyl isocyanate with an alcohol in toluene or CH<SB>3</SB>CN to prepare a reaction product; (b) a step of adding a compound selected from the group consisting of pyridine, a substituted pyridine and quinolines to the reaction product formed in the step (a), to prepare a reaction product; and (c) a step of adding aqueous ammonia to the reaction product prepared in the step (b), to prepare the sulfamide. The method for synthesizing the pyrrolidylthiocarbapenem derivative includes the above method for synthesizing a sulfamide as one step. <P>COPYRIGHT: (C)2008,JPO&amp;INPIT

Description

(Technical field to which the invention belongs)
The present invention relates to a method for producing an acetylthiopyrrolidine derivative. Specifically, the present invention relates to synthesizing carbapenem antibiotics under conditions that are much more relaxed (eg, avoiding low temperatures) than conventional synthetic methods. The present invention also provides a method for synthesizing pyrrolidylthiocarbapenem derivatives with minimal use of halogen-containing solvents that are considered environmental pollutants.

(Conventional technology)
Pyrrolidylthiocarbapenem derivatives (I) having a broad antibacterial spectrum

は、有用な抗生物質として合成され、現在有望な次世代抗生物質として開発中である（特許文献１）（この式において、Ｒ¹は水素または低級アルキルであり、Ｒ²、Ｒ³およびＲ⁴はそれぞれ独立して、水素、低級アルキル、置換された低級アルキル、またはアミノ基の保護基であり、あるいは、Ｒ²とＲ³とが窒素原子とともに飽和もしくは不飽和の環式基を形成するか、またはＲ²もしくはＲ³とＲ⁴とが窒素原子２個と硫黄原子１個と共に飽和もしくは不飽和の環式基を形成し、この環式基はそれぞれ、さらに酸素、硫黄および窒素からなる群より選択される少なくとも１種を有し得、この環式基はそれぞれ置換され得、Ｘ¹は水素または水酸基の保護基であり、Ｘ²は、水素、カルボキシル基の保護基、アンモニオ基、アルカリ金属またはアルカリ土類金属であり、そしてＹ²は水素またはアミノ基の保護基である。）。特許文献１では、上記カルバペネム誘導体を製造するための中間体となるピロリジン誘導体およびそのピロリジン誘導体を製造する方法のいくつかが開示された。

Is synthesized as a useful antibiotic and is currently under development as a promising next generation antibiotic ( Patent Document 1 ) (in this formula, R ¹ is hydrogen or lower alkyl, R ² , R ³ and R ⁴ Are each independently hydrogen, lower alkyl, substituted lower alkyl, or amino protecting group, or whether R ² and R ³ together with the nitrogen atom form a saturated or unsaturated cyclic group Or R ² or R ³ and R ⁴ together with two nitrogen atoms and one sulfur atom form a saturated or unsaturated cyclic group, each cyclic group further comprising the group consisting of oxygen, sulfur and nitrogen And each cyclic group may be substituted, X ¹ is hydrogen or a hydroxyl protecting group, X ² is hydrogen, a carboxyl protecting group, an ammonio group, an alkali Metal or An alkaline earth metal, and Y ² is a protecting group of hydrogen or an amino group.). Patent Document 1 discloses a pyrrolidine derivative serving as an intermediate for producing the carbapenem derivative and several methods for producing the pyrrolidine derivative.

However, the synthesis method used in Patent Document 1 requires a reaction at a considerably low temperature such as −20 ° C. and −25 ° C. using a halogen-containing solvent such as dichloromethane as a solvent. However, since halogen-containing solvents cause environmental pollution, it is desirable to avoid their use as much as possible in current methods for synthesizing compounds. In addition, in order to maintain a reaction system at a low temperature such as −20 ° C., special experimental equipment is required, and the synthesis method becomes complicated, so that the reaction system is at room temperature or near room temperature as much as possible. It is desirable to complete all or most of the steps.

In order to synthesize the pyrrolidylthiocarbapenem derivative, it is generally necessary to synthesize t-butoxycarbonyl-sulfamide as an intermediate. However, in a conventional sulfamide synthesis method (for example, Patent Document 2 ), a reaction system is complicated because a method using ammonia gas is employed. Further, since a long-time reaction at a considerably low temperature such as −40 ° C. or −65 ° C. is required, a reaction system that maintains a low temperature is required.

In addition, in the process of synthesizing a useful intermediate thiolpyrrolidine from L-hydroxyproline, the conventional method uses a reduction reaction at −45 ° C. in dichloromethane or a long-time reaction at −65 ° C. And so on. Accordingly, conventional methods for synthesizing pyrrolidylthiocarbapenem derivatives require improvements.
Japanese Patent No. 2554273 JP-A-5-72986

  Thus, the present invention provides an intermediate synthesis that does not use or reduces the use of halogen-containing solvents and / or avoids or reduces extreme high and / or low temperatures in a method of synthesizing pyrrolidylthiocarbapenem derivatives. It is an object of the present invention to provide a process or a method for synthesizing a pyrrolidylthiocarbapenem derivative using them.

  The present invention eliminates or reduces the use of halogen-containing solvents and / or avoids or reduces extreme high and / or low temperatures for sulfamide, which is one of the synthetic intermediates of pyrrolidylthiocarbapenem derivatives A synthesis method is provided.

  The present invention relates to 4-nitrobenzyloxycarbonyl substituted hydroxyl groups and carboxyls without using or reducing halogen-containing solvents and / or avoiding or reducing extreme high and / or low temperatures. Provided is a method for converting a hydroxyl group of a heterocyclic compound containing a group into a methylsulfonyloxy group and a carboxyl group into a hydroxymethyl group.

  The present invention relates to 4-nitrobenzyloxycarbonyl substituted hydroxyl groups and carboxyls without using or reducing halogen-containing solvents and / or avoiding or reducing extreme high and / or low temperatures. Provided is a method for converting a hydroxyl group of a heterocyclic compound containing a group into a methylsulfonyloxy group and a carboxyl group into a hydroxymethyl group.

  The present invention relates to methylsulfonyloxy groups substituted with 4-nitrobenzyloxycarbonyl while avoiding or reducing the use of halogen-containing solvents and / or avoiding or reducing extreme high and / or low temperatures. And a method for converting a methylsulfonyloxy group of a heterocyclic compound containing a hydroxymethyl group into an acetylthio group.

  The present invention provides for the use of 4-nitrobenzyloxycarbonyl substituted acetylthio groups and hydroxy while avoiding or reducing the use of halogen-containing solvents and / or avoiding or reducing extreme high and / or low temperatures. Provided is a method for converting a carboxyl group of a heterocyclic compound containing a methyl group into a sulfamoyl-tert-butoxycarboxamidomethyl group.

  The present invention does not use or reduce the use of halogen-containing solvents and / or avoids extreme high and / or low temperatures by including at least one step of carrying out the method of preparing the above intermediates Methods of synthesizing thiol pyrrolidine while providing or reducing are provided.

  The present invention does not use or reduce the use of halogen-containing solvents and / or avoids extreme high and / or low temperatures by including at least one step of carrying out the method of preparing the above intermediates While doing or reducing,

で示される化合物（本明細書において、「化合物Ａ」とも称する）、その塩または水和物を合成する方法を提供する。

A method for synthesizing a compound represented by the formula (also referred to herein as “compound A”), a salt or a hydrate thereof is provided.

  The present invention is described in detail below.

The present invention provides a method for synthesizing sulfamide, which is one of the synthesis intermediates of pyrrolidylthiocarbapenem derivatives, while avoiding reactions at low temperatures. This method comprises the following steps:
a) a step of reacting a halogenated sulfonyl isocyanate and an alcohol in a solvent to obtain a reaction product;
b) adding a compound selected from the group consisting of pyridine, substituted pyridines and quinolines to the reaction product obtained in step a) to obtain a reaction product;
And c) adding ammonia water to the reaction product obtained in step b) to obtain sulfamide,
Is included. Here, examples of the solvent include toluene, CH ₃ CN, ethyl acetate and the like.

In one embodiment, in the above method, the sulfamide may be Boc sulfamide, where Boc is tert-butoxycarbonyl.
The halogenated sulfonyl isocyanate can be chlorosulfonyl isocyanate, and the alcohol can be tert-butanol.

  In another embodiment, in the method of the present invention, at least one of the above steps a) to c) can be performed at room temperature to under cooling, preferably at 0 ° C to -30 ° C.

In another embodiment, the reaction product of the above step _a), ClSO 2 NHC (CO) may be a Ot-Bu (here, t-Bu is tert- butyl).

In another embodiment, the reaction product of step b) above may be a _{ClSO 2 NHC (CO) Ot-} Bu pyridinium salts, salts selected from the group consisting of salts of substituted pyridinium salts and quinolines .

In another aspect, the present invention converts a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a hydroxyl group and a carboxyl group into a methylsulfonyloxy group and a carboxyl group into a hydroxymethyl group, respectively. Provide a method. This method
a) reacting the 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a hydroxyl group and a carboxyl group with ROH in the presence of an acid to obtain a reaction product, wherein Wherein R is C1-C6 alkyl;
b) a step of reacting the reaction product of step a) with methanesulfonyl halide in ethyl acetate in the presence of triethylamine to obtain a reaction product;
c) The reaction product of step b) is reduced with NaBH ₄ in ethyl acetate in the presence of alcohol to give a 4-nitrobenzyloxycarbonyl substituted heterosulfonyl containing methylsulfonyloxy and hydroxymethyl groups. Obtaining a ring compound;
Is included.

  In one embodiment, the 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a hydroxyl group and a carboxyl group is a PPR.

であり得、
上記４−ニトロベンジルオキシカルボニル置換された、メチルスルホニルオキシ基およびヒドロキシメチル基を含むへテロ環化合物は、ＰＬＭ

Could be
The 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a methylsulfonyloxy group and a hydroxymethyl group is PLM.

であり得、
上記酸が、ＳＯＣｌ₂、Ｈ₂ＳＯ₄またはＨＣｌであり得、上記ハロゲン化メタンスルホニルが、塩化メタンスルホニルであり得、そして上記アルコールが、メタノールであり得る。ここで、ＰＮＺは、４−ニトロベンジルオキシカルボニルであり、Ｍｓは、メタンスルホニルである。

Could be
The acid be a SOCl _2, H ₂ SO ₄ or HCl, the halogenated methanesulfonyl may be a methanesulfonyl chloride, and the alcohol may be methanol. Here, PNZ is 4-nitrobenzyloxycarbonyl and Ms is methanesulfonyl.

  In one embodiment, step a) above is performed at 0 ° C to 30 ° C. In another embodiment, step b) above is performed at 0 ° C to 30 ° C. In another embodiment, step c) above is performed at 0 ° C to 30 ° C.

  In another embodiment, the reaction product of step a) above is R-PPR.

である。ここで、Ｒはアルキル基である。好ましくは、Ｒは、Ｃ１〜Ｃ６アルキルであり得る。

It is. Here, R is an alkyl group. Preferably R may be C1-C6 alkyl.

  In another embodiment, the reaction product of step b) above is PNC-Ms

である。

It is.

  Preferably, the C1-C6 alkyl is methyl or ethyl. More preferably, the C1-C6 alkyl is methyl.

  In another aspect, the present invention converts a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a hydroxyl group and a carboxyl group into a methylsulfonyloxy group and a carboxyl group into a hydroxymethyl group, respectively. Provide a method.

This method
a) a step of reacting the heterocyclic compound with an alkyl halocarbonate in ethyl acetate in the presence of tributylamine to obtain a reaction product;
b) a step of reacting the reaction product obtained in step a) with methanesulfonyl halide in the presence of triethylamine to obtain a reaction product;
c) Reduction of the reaction product obtained in step b) with an aqueous NaBH ₄ solution in the presence of an alcohol, and a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a methylsulfonyloxy group and a hydroxymethyl group Obtaining a step,
Is included.

  In one embodiment, the 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a hydroxyl group and a carboxyl group is a PPR.

であり得る。

It can be.

  The 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a methylsulfonyloxy group and a hydroxymethyl group is PLM.

であり得る。

It can be.

  The alkyl halocarbonate can be ethyl chlorocarbonate. The methanesulfonyl halide can be methanesulfonyl chloride. The alcohol can be isopropanol.

  Preferably, step a) is performed at -30 ° C to -40 ° C. Preferably, step b) is performed at -40 ° C to -50 ° C. Preferably, step c) is performed at -40 ° C to -50 ° C.

  In one embodiment, the reaction product of step b) above is PRE

である。

It is.

In another aspect, the present invention relates to the conversion of a hydroxyl group of a heterocyclic compound containing a hydroxyl group and a carboxyl group into a methylsulfonyloxy group, a carboxyl group into a -COOR group, and 4 on the heteroatom of the heterocyclic compound. A method for introducing a nitrobenzyloxycarbonyl group, wherein R is C1-C6 alkyl. This method comprises the following steps:
a) a step of reacting the heterocyclic compound containing the hydroxyl group and carboxyl group with ROH in the presence of a reagent selected from acids to obtain a reaction product;
b) a step of reacting the reaction product of step a) with 4-nitrobenzyloxycarbonyl halide in the presence of an alkali metal carbonate to obtain a reaction product;
c) The reaction product of step b) is reacted with methanesulfonyl halide in toluene in the presence of triethylamine to give 4-nitrobenzyloxycarbonyl substituted heteroaryl containing methylsulfonyloxy group and —COOR group Obtaining a ring compound;
Is included.

  In one embodiment, the above heterocyclic compound containing a hydroxyl group and a carboxyl group is HYP.

であり得、上記４−ニトロベンジルオキシカルボニル置換された、メチルスルホニルオキシ基および−ＣＯＯＲ基を含むへテロ環化合物は、ＭＰＲＭ

The 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a methylsulfonyloxy group and a —COOR group can be represented by MPRM

であり得（式中、ＭｓおよびＰＮＺは前記と同義である）、上記酸が、ＳＯＣｌ₂、ＰＯＣｌ₃およびＨＣｌから選択される試薬であり、上記アルカリ金属は、ナトリウムまたはカリウムであり得、そして上記ハロゲン化メタンスルホニルは、塩化メタンスルホニルであり得る。

Wherein Ms and PNZ are as defined above, the acid is a reagent selected from SOCl ₂ , POCl ₃ and HCl, the alkali metal can be sodium or potassium, and The methanesulfonyl halide can be methanesulfonyl chloride.

  Preferably step b) is carried out at 0-5 ° C. Preferably, step c) is performed at 10 to 32 ° C.

The present invention further provides another method for the synthesis of methyl MPRM (Scheme 1). In this method, HYP is converted to PNZ and then esterified, whereby the process of using PNZ-Cl, which is relatively difficult to obtain, can be performed separately, and there is an advantage that flexibility in selecting a manufacturing site can be given. . For the isolation of PPR, a neutralization crystallization method that is simple in extraction operation and avoids concentration operation can be applied. PPR obtained by this neutralization crystallization method was a monohydrate.
Scheme 1

１つの局面において、本発明は、４−ニトロベンジルオキシカルボニル置換された、メチルスルホニルオキシ基およびヒドロキシメチル基を含むヘテロ環化合物のメチルスルホニルオキシ基を、アセチルチオ基へと変換する方法を提供する。

In one aspect, the present invention provides a method for converting a methylsulfonyloxy group of a heterocyclic compound containing a methylsulfonyloxy group and a hydroxymethyl group, substituted with 4-nitrobenzyloxycarbonyl, into an acetylthio group.

This method comprises the following steps:
a) Mixing of the above heterocyclic compound substituted with 4-nitrobenzyloxycarbonyl and containing methylsulfonyloxy group and hydroxymethyl group with potassium thioacetate in acetonitrile / water, dimethylformamide / ethyl acetate or dimethylformamide / toluene Reacting in a solvent to obtain a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing an acetylthio group and a hydroxymethyl group;
Is included.

  In one embodiment, the 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a methylsulfonyloxy group and a hydroxymethyl group is PLM.

であり得、上記４−ニトロベンジルオキシカルボニル置換された、アセチルチオ基およびヒドロキシメチル基を含むヘテロ環化合物は、ＡＴＰ

And the 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing an acetylthio group and a hydroxymethyl group is ATP.

であり得る。ここで、Ａｃはアセチルである。好ましくは、上記アセトニトリル／水の混合溶媒は、１０容：０．１容〜５容：５容の比の混合溶媒であり得る。

It can be. Here, Ac is acetyl. Preferably, the mixed solvent of acetonitrile / water may be a mixed solvent in a ratio of 10 volume: 0.1 volume to 5 volume: 5 volume.

  In one embodiment, step a) above can be heated to 65-80 ° C. for 2-10 hours. Preferably step a) above may be carried out at 80 ° C. for 1 to 3 hours or under heating conditions substantially similar thereto.

In one preferred embodiment, pyrrolidine mesylate (PLM) can be synthesized from PNZ-proline (PPR) by the method of the present invention, and acetylthiopyrrolidine (ATP) can be synthesized from the resulting PLM by the method of the present invention. . In this embodiment, preferably the acid is H ₂ SO ₄ . As shown in Example 15 described later, this production method has an advantage that ATP can be easily synthesized without performing purification operations other than extraction operations on intermediates (MPRM and PLM).

In another aspect, the present invention relates to a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a methylsulfonyloxy group and a -COOR group, wherein the methylsulfonyloxy group is an acetylthio group, and the -COOR group is a hydroxymethyl group. Each method of conversion, wherein R is C1-C6 alkyl, is provided. This method comprises the following steps:
a) reducing the heterocyclic compound with NaBH ₄ in the presence of an alcohol to obtain a reaction product;
b) A heterocycle containing an acetylthio group and a hydroxymethyl group, which is obtained by reacting the reaction product of step a) with potassium thioacetate in a mixed solvent of dimethylformamide / ethyl acetate and substituted with 4-nitrobenzyloxycarbonyl. Obtaining a compound;
Is included.

  In one embodiment, the 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a methylsulfonyloxy group and a —COOR group is an MPRM.

であり得（式中、ＭｓおよびＰＮＺは前記と同義である）、上記４−ニトロベンジルオキシカルボニル置換された、アセチルチオ基およびヒドロキシメチル基を含むヘテロ環化合物が、ＡＴＰ

Wherein Ms and PNZ are as defined above, and the 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing an acetylthio group and a hydroxymethyl group is ATP.

であり得、上記Ｒが、メチルであり得、そして上記アルコールが、メタノールであり得る。

The R can be methyl and the alcohol can be methanol.

  In one embodiment, preferably step a) above may be carried out at 0-5 ° C. Preferably, step b) above can be heated to 60-70 ° C. for 8-10 hours. Preferably, the mixed solvent of dimethylformamide / ethyl acetate may be a mixed solvent in a ratio of 10 volume: 0 volume to 10 volume: 1 volume.

  In one preferred embodiment, mesylproline methyl ester (MPRM) is synthesized from L-hydroxyproline (HYP) by the method of the present invention, and acetylthiopyrrolidine (ATP) is synthesized from the resulting MPRM by the method of the present invention. Then, acetylthiosulfamide (ATS) can be synthesized from the obtained ATP by the method of the present invention. In accordance with this embodiment, as shown in Examples 11 and 12 below, the number of isolations and extractions can be significantly reduced, thereby significantly reducing the number of manufacturing days and achieving high productivity.

In another aspect, the present invention provides a method for converting a hydroxymethyl group of a heterocyclic compound containing 4-nitrobenzyloxycarbonyl substituted acetylthio group and hydroxymethyl group to a sulfamoyl-tert-butoxycarboxamidomethyl group. To do. This method comprises the following steps:
The 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing an acetylthio group and a hydroxymethyl group is reacted with Boc sulfamide in ethyl acetate in the presence of triphenylphosphine and diisopropyl azodicarboxylic acid to give 4- Obtaining a heterocyclic compound substituted with nitrobenzyloxycarbonyl and containing an acetylthio group and a sulfamoyl-tert-butoxycarboxamidomethyl group.

  In one embodiment, the 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing an acetylthio group and a hydroxymethyl group is ATP.

であり得、
上記４−ニトロベンジルオキシカルボニル置換された、アセチルチオ基およびスルファモイル−ｔｅｒｔ−ブトキシカルボキサミドメチル基を含むヘテロ環化合物は、ＡＴＳ

Could be
The heterocyclic compound containing 4-nitrobenzyloxycarbonyl-substituted acetylthio group and sulfamoyl-tert-butoxycarboxamidomethyl group is ATS.

であり得る。ここで、Ｂｏｃは、ｔｅｒｔ−ブトキシカルボニルである。

It can be. Here, Boc is tert-butoxycarbonyl.

  In another embodiment, the above steps of the method of the invention may be performed at -20 ° C to 25 ° C. Preferably, the above step can be performed at 18 to 21 ° C.

  In one embodiment, a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing an acetylthio group and a hydroxymethyl group is used in the method for converting a hydroxymethyl group into a sulfamoyl-tert-butoxycarboxamidomethyl group. Boc sulfamide may have been synthesized by the method of the present invention.

  In another aspect, the present invention provides a method of synthesizing thiol pyrrolidine, which method includes at least one of the above intermediate synthesis methods of the present invention.

In another aspect, the present invention provides a method of synthesizing thiol pyrrolidine. This method
Sulphamide is synthesized by the method of the present invention,
In the method of the present invention, a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a hydroxyl group and a carboxyl group is substituted with a 4-nitrobenzyloxycarbonyl-substituted heterocyclic ring containing a methylsulfonyloxy group and a hydroxymethyl group. Synthesize compounds,
According to the method of the present invention, a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing a methylsulfonyloxy group and a hydroxymethyl group is converted into a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing an acetylthio group and a hydroxymethyl group. Synthesizing a ring compound, and
In the method of the present invention, 4-nitrobenzyloxycarbonyl-substituted acetylthio group and sulfamoyl-tert are substituted from the sulfamide and a 4-nitrobenzyloxycarbonyl-substituted heterocyclic compound containing an acetylthio group and a hydroxymethyl group. Synthesizing heterocyclic compounds containing butoxycarboxamidomethyl groups, and deprotection reactions,
Is included.

In one embodiment, the present invention provides a method of synthesizing thiol pyrrolidine. This method
By the method of the present invention, Boc sulfamide is synthesized from chlorosulfonyl isocyanate,
By the method of the present invention, PPR

から、ＰＬＭ

To PLM

を合成し、
本発明の方法によって、ＰＬＭ

Synthesize
By the method of the present invention, PLM

から、ＡＴＰ

To ATP

を合成し、そして
本発明の方法によって、上記Ｂｏｃスルファミドと、ＡＴＰ

And by the method of the present invention, the Boc sulfamide and ATP

とから、ＡＴＳ

And ATS

を合成すること、ならびに脱保護反応、
を包含する。

As well as deprotection reactions,
Is included.

  The present invention also provides a method for producing a pyrrolidylthiocarbapenem derivative represented by the above formula (I) by coupling SPL obtained from ATS and a known enol phosphate (ELP-PNB).

  Particularly in this production method, as shown in Example 8 described later, in the extraction operation after the deprotection reaction of TCE obtained by the coupling reaction, a metal halide, a mixture of water and an organic solvent, preferably tetrahydrofuran, Preferably, by adding about 5 to 50% by weight, preferably about 20 to 40% by weight, of magnesium chloride with respect to TCE, an aqueous solution in which the target compound is dissolved at a high concentration can be prepared. As a result, the target pyrrolidylthiocarbapenem derivative can be isolated as a crystal with high purity without performing a concentration operation or column chromatography process that has been indispensable in the post-treatment process. Therefore, it is also useful as an industrial production method. In this isolation operation, a seed crystal of the target product is preferably used.

  The present invention also provides a TCE

で示される化合物を製造する方法を提供する。この方法は、以下の工程：
４−ニトロベンジル（１Ｒ，５Ｒ，６Ｓ）−［（Ｒ）−１−ヒドロキシエチル］−２−オキソ−カルバペネム−３−カルボキシレートとジフェニルホスホクロリデートとを反応させて、以下の化合物：ＥＬＰ−ＰＮＢ

The method of manufacturing the compound shown by this is provided. This method comprises the following steps:
4-Nitrobenzyl (1R, 5R, 6S)-[(R) -1-hydroxyethyl] -2-oxo-carbapenem-3-carboxylate and diphenylphosphochloridate are reacted to form the following compound: ELP- PNB

を得る工程；および
該ＥＬＰ−ＰＮＢと、以下の化合物：ＳＰＬ

And the ELP-PNB and the following compound: SPL

とを反応させて、ＴＣＥ

And react with TCE

を得る工程、を包含する。

Obtaining.

  In one embodiment, the ELP-PNB can be reacted with the SPL without isolation from the reaction solution.

  The present invention also provides a method for producing a TCE crystal comprising a step of obtaining a crystal from the reaction solution containing TCE obtained in the above method of the present invention or an extract thereof.

  In one embodiment, the step of obtaining the crystal may include adding an alcohol to the reaction solution or an extract thereof.

  The present invention also provides the following formula:

で示される化合物を合成する方法を提供する。この方法は、合成工程として本発明の中間体合成方法を少なくとも１つ包含する。好ましくは、本発明の方法は、合成工程として本発明の中間体合成方法を少なくとも２つ包含する。より好ましくは、本発明の方法は、可能な中間体合成経路において本発明の中間体合成方法をすべて包含する。１つの実施態様において、本発明は、合成工程として上記方法を包含する、医薬品の製造方法を提供する。

A method for synthesizing a compound represented by the formula: This method includes at least one intermediate synthesis method of the present invention as a synthesis step. Preferably, the method of the present invention includes at least two intermediate synthesis methods of the present invention as synthesis steps. More preferably, the method of the invention encompasses all of the intermediate synthesis methods of the invention in possible intermediate synthesis routes. In one embodiment, the present invention provides a method for producing a pharmaceutical, comprising the above method as a synthesis step.

In another aspect, the present invention also provides the following compound or crystal.
PPR

ＰＲＥ

PRE

ＡＴＰ

ATP

、およびＡＴＳ

, And ATS

。

.

  The present invention further shows that in the powder X-ray diffraction analysis, the 2θ values are 4.580 ± 0.100, 9.060 ± 0.100, 18.100 ± 0.100 and 22.660 which show main peaks of 22.660. Provide crystals.

  The present invention also has main peaks at 2θ values of 6.920 ± 0.100, 7.000 ± 0.100, 11.700 ± 0.100 and 20.140 ± 0.100 in powder X-ray diffraction analysis. ATS crystals exhibiting

  In the powder X-ray diffraction analysis, the present invention also shows main peaks at 2θ values of 19.100 ± 0.100, 22.620 ± 0.100 and 26,000 ± 0.100, and has the following structure: PLM

の化合物の結晶を提供する。

A crystal of the compound is provided.

  The present invention also shows the following structure in powder X-ray diffraction analysis showing the main peaks at 2θ values of 15.910 ± 0.100, 19.930 ± 0.100 and 25.400 ± 0.100: TCE

の化合物の結晶を提供する。

A crystal of the compound is provided.

  In accordance with the present invention, it has been achieved to synthesize pyrrolidylthiocarbapenem derivatives without using or reducing the use of halogen-containing solvents and / or avoiding or reducing extreme high and / or low temperatures.

(Embodiment of the Invention)
The terms used in the present specification are used in the meaning usually used in the art, either individually or in combination, unless otherwise specified.
(Abbreviation)
Hereinafter, abbreviations used in this specification will be described.
BSA (Boc sulfamide): N-tert-butoxycarbonylsulfamide PPR (PNZ proline): (2S, 4R) -4-hydroxy-1- (4-nitrobenzyloxycarbonyl) pyrrolidine-2-carboxylic acid PLM (pyrrolidine) Mesylate): 4-nitrobenzyl (2S, 4R) -2-hydroxymethyl-4-methylsulfonyloxypyrrolidine-1-carboxylate R-PPR: (2S, 4R) -4-hydroxy-1- (4-nitro Benzyloxycarbonyl) pyrrolidine-2-carboxylic acid ester PNC-Ms: (2S, 4R) -4-methylsulfonyloxy-1- (4-nitrobenzyloxycarbonyl) pyrrolidine-2-carboxylic acid ester PRE: (2S, 4R ) -4-Methylsulfonyloxy-1- (4-nitrate) Benzyloxycarbonyl) pyrrolidine-2-carboxylic acid alkyl carbonate ATP (acetylthiopyrrolidine): 4-nitrobenzyl (2S, 4S) -4-acetylthio-2-hydroxymethylpyrrolidine-1-carboxylate ATS (acetylthiosulfamide) ): 4-nitrobenzyl (2S, 4S) -4-acetylthio-2- (N-sulfamoyl-tert-butoxycarboxamidomethyl) pyrrolidine-1-carboxylate SPL (thiolpyrrolidine): 4-nitrobenzyl (2S, 4S) -4-mercapto-2-sulfamoylaminomethylpyrrolidine-1-carboxylate TCE (thiopyrrolidine carbapenem ester): 4-nitrobenzyl (4R, 5S, 6S) -6-[(1R) -1-hydroxyethyl] -4-methyl -3-[[(3S, 5S) -1- (4-nitrobenzyloxycarbonyl) -5- (sulfamoylaminomethyl) pyrrolidin-3-yl] thio] -7-oxo-1-azabicyclo [3. 2.0] hept-2-ene-2-carboxylate (Definition)
“Pyrrolidylthiocarbapenem derivative” means a structure in which the 2-position of the carbapenem-based compound (however, according to the IUPAC nomenclature is the 3-position) is substituted with a pyrrolidylthio group

を有する化合物をいう。ピロリジルチオカルバペネム誘導体は、抗生物質活性を有することが知られている（特許第２５４２７７３号）。

The compound which has this. The pyrrolidylthiocarbapenem derivative is known to have antibiotic activity (Japanese Patent No. 2554273).

“Sulfamide”, “sulfamides” and “sulfamide compound” are used interchangeably herein and refer to a compound having a —NSO ₂ NH— structure. Sulfamide is known as a pharmaceutically useful compound of pharmaceuticals, foods, animal and plant drugs, polymer chemistry, and stereoisomeric alcohol compounds. Such useful compounds include beta-lactam antibacterial agents, antipyretics, analgesics (A. Girraldes et al., Eur. J. Med. Chem. (1989) 24, 497), sweeteners (J. Org. Chem). (1989), 54, 4471), sleeping agents (B. Unhalt et al., Arch. Pharm. (Weinheim) 1988, 321, 375), anticonvulsants (C. H. Lee et al., J. Pharm. Sci. 1990). 79, 716).

  “Halogen-containing solvent” refers to a solvent containing a halogen element. “Halogen” is an element belonging to Group 17 of the periodic table. Examples of halogen include fluorine (F), chlorine (Cl), bromine (Br), and iodine (I). “Halogenation” refers to the replacement of hydrogen in a compound with halogen.

  In this specification, “low temperature” means a temperature considerably lower than around room temperature, and a special apparatus is usually required when the reaction is performed under low temperature reaction conditions. Specific examples of the low temperature include, but are not limited to, −60 ° C. or lower, −40 ° C. or lower, −20 ° C. or lower, 0 ° C. or lower, 10 ° C. or lower. Further, “extremely low temperature” refers to a temperature of −40 ° C. or less, for example. In this specification, “high temperature” means a temperature considerably higher than around room temperature. Specific examples of the high temperature include, but are not limited to, 100 ° C. or higher, 80 ° C. or higher, 60 ° C. or higher, 50 ° C. or higher, 40 ° C. or higher, 30 ° C. or higher. In this specification, “extremely high temperature” means, for example, 80 ° C. or higher. Such low or high temperature reaction conditions are generally less desirable because they require specialized reaction systems. Accordingly, when synthesizing the compound, it is preferable to avoid or reduce such low and / or high temperature conditions.

  “4-Nitrobenzyloxycarbonyl (group)” means

で表される基をいい、本明細書において、ときに、ＰＮＺと表記する。ＰＮＺ基は、Ｂｏｃなどと並んで有用な保護基である。

In the present specification, sometimes referred to as PNZ. The PNZ group is a useful protecting group along with Boc and the like.

  “Carboxy (group)” refers to a group represented by —COOH.

  “Hydroxy (group)” refers to a group represented by —OH.

  “Heterocycle (group)” refers to a group having a cyclic structure including carbon and heteroatoms. Here, the heteroatoms are selected from the group consisting of O, S and N, and may be the same or different, and may be contained in one or more than one. Heterocyclic groups can be aromatic or non-aromatic and can be monocyclic or polycyclic. The heterocyclic group may be substituted.

“Methylsulfonyloxy (group)” refers to a group represented by —OSO ₂ CH ₃ .

“Hydroxymethyl (group)” refers to a group represented by —CH ₂ OH.

“Acetylthio (group)” refers to a group represented by —S—COCH ₃ .

“Sulfamoyl-tert-butoxycarboxamidomethyl (group)” refers to a group represented by CH ₂ N (Boc) SO ₂ NH ₂ .

“Tert-butoxycarbonyl (group)” is also referred to herein as “Boc” and refers to a group represented by —COOC (CH ₃ ) ₃ . Boc is a useful protecting group.

  “Thiolpyrrolidine” refers to a compound in which a thiol group is substituted in place of hydrogen of pyrrolidine or a derivative thereof.

“Acid” refers to acids in a broad sense including mineral acids, organic acids and Lewis acids. Examples of the mineral acid include, but are not limited to, hydrochloric acid, sulfuric acid, nitric acid, and phosphoric acid. Examples of the organic acid include, but are not limited to, p-toluenesulfonic acid. The Lewis acids, such as, but like SOCl _2, POCl _3, AlCl ₃ and BF ₃ and the like without limitation.

  “Alcohol” refers to an organic compound in which one or more hydrogen atoms of an aliphatic hydrocarbon are substituted with a hydroxyl group. In the present specification, it is also expressed as ROH. Here, R is an alkyl group. Preferably R may be C1-C6 alkyl. Examples of alcohol include, but are not limited to, methanol, ethanol, 1-propanol, 2-propanol (isopropanol), tert-butanol, and the like.

“Alkyl” refers to a monovalent group formed by loss of one hydrogen atom from an aliphatic hydrocarbon such as methane, ethane, or propane, and is generally represented by C _n H _{2n + 1} — , N is a positive integer). Alkyl can be linear or branched and can be cyclic or acyclic. As used herein, “substituted alkyl” refers to alkyl in which H of alkyl is substituted. Specific examples thereof include C1-C2 alkyl, C1-C3 alkyl, C1-C4 alkyl, C1-C5 alkyl, C1-C6 alkyl, C1-C7 alkyl, C1-C8 alkyl, C1-C9 alkyl, C1-C10 alkyl. C1-C11 alkyl or C1-C12 alkyl, C1-C2 substituted alkyl, C1-C3 substituted alkyl, C1-C4 substituted alkyl, C1-C5 substituted alkyl, C1-C6 substituted alkyl C1-C7 substituted alkyl, C1-C8 substituted alkyl, C1-C9 substituted alkyl, C1-C10 substituted alkyl, C1-C11 substituted alkyl or C1-C12 substituted alkyl obtain. Here, for example, C1-C10 alkyl means linear or branched alkyl having 1 to 10 carbon atoms, methyl (CH ₃ —), ethyl (C ₂ H ₅ —), n-propyl. _{(CH 3 CH 2 CH 2 -} ), isopropyl _{((CH 3) 2 CH -} ), n- butyl _{(CH 3 CH 2 CH 2 CH} 2 -), n- pentyl _{(CH 3 CH 2 CH 2 CH} 2 CH 2 -), n-hexyl _{(CH 3 CH 2 CH 2 CH} 2 CH 2 CH 2 -), n- heptyl _{(CH 3 CH 2 CH 2 CH} 2 CH 2 CH 2 CH 2 -), n- octyl (CH ₃ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ —), n-nonyl (CH ₃ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ —), n-decyl (CH ₃ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH ₂ CH _2- ), -C (CH ₃ ) ₂ CH Examples of ₂ CH ₂ CH (CH ₃ ) ₂ , —CH ₂ CH (CH ₃ ) ₂ and cycloalkyl include cyclopropyl and cyclohexyl. In addition, for example, C1-C10 substituted alkyl refers to C1-C10 alkyl, in which one or more hydrogen atoms are substituted with a substituent.

  In the present specification, unless otherwise specified, substitution refers to replacement of one or more hydrogen atoms in an organic compound or substituent with another atom or atomic group. One hydrogen atom can be removed and substituted with a monovalent substituent, and two hydrogen atoms can be removed and substituted with a divalent substituent.

  Substituents include alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkenyl, substituted alkenyl, cycloalkenyl, substituted cycloalkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy , Carbocyclic group, substituted carbocyclic group, heterocyclic group, substituted heterocyclic group, halogen, hydroxy, substituted hydroxy, thiol, substituted thiol, cyano, nitro, amino, substituted amino, Carboxy, carbamoyl, substituted carboxy, acyl, acylamino, substituted acyl, thiocarboxy, substituted thiocarboxy, amide, substituted amide, substituted carbonyl, substituted thiocarbonyl, substituted sulfonyl or Substituted sulfini But it is not limited to these. When the above substituent is a substituted group, the substituent for the further substitution can be selected in the same manner as described above.

“Isocyanate” refers to a compound having —N═C═O. Examples of the isocyanate include, but are not limited to, methyl isocyanate CH ₃ N═C═O, sulfonyl isocyanate OSO ₂ —N═C═O, and the like.

“Methanesulfonyl” refers to a group represented by CH ₃ SO ₂ —.

  “Alkylhalocarbonate” refers to a compound represented by XCOOR, where X is a halogen group and R is alkyl. Examples of the alkyl halocarbonate include ethyl chlorocarbonate.

“Acetonitrile” is a compound represented by CH ₃ CN. “Dimethylformamide” and “DMF” are compounds represented by (CH ₃ ) ₂ NCHO. A mixed solvent of acetonitrile / water refers to a solvent in which acetonitrile and water are mixed in an arbitrary ratio. The ratio of acetonitrile to water is preferably 10 volumes: 0.1 volume to 5 volumes: 5 volumes, but is not limited thereto. The mixed solvent of dimethylformamide / toluene refers to a solvent in which dimethylformamide and toluene are mixed in an arbitrary ratio. The ratio of dimethylformamide and toluene is preferably, but not limited to, a ratio of 10 volume: 0 volume to 1 volume: 10 volume. The mixed solvent of dimethylformamide / ethyl acetate refers to a solvent in which dimethylformamide and ethyl acetate are mixed in an arbitrary ratio. The ratio of dimethylformamide to ethyl acetate is preferably, but not limited to, a ratio of 10 volume: 0 volume to 1 volume: 10 volume.

  “Deprotection reaction” refers to a reaction for removing a protecting group such as Boc or PNZ. Examples of the deprotection reaction include a reaction such as a reduction reaction using Pd / C.

  In each method of the present invention, the target product is mixed with impurities (unreacted weight loss, by-products, solvent, etc.) from the reaction solution, and a method commonly used in the art (for example, extraction, distillation, washing, concentration). , Precipitation, filtration, drying, etc.) followed by a combination of post-treatment methods commonly used in the art (eg, adsorption, elution, distillation, precipitation, precipitation, chromatography, etc.).

  In this specification, in order to determine the physical property of the obtained compound, the analysis method using powder X-ray diffraction is used.

  In one aspect, the present invention provides a method for conveniently obtaining TCE crystals. This method includes a step of reacting the ELP-PNB of the present invention with the SPL after or without isolation from the reaction solution. Preferably, this step includes a step of adding an alcohol (for example, methanol) to the reaction solution containing TCE obtained in the method of the present invention or an extract thereof. The fact that a TCE crystal for X-ray analysis can be obtained without isolating the TCE precursor is a special effect that has not been predicted in the past.

  In this specification, the physical property of a compound can be specified by the analysis result by the said X-ray diffraction. The specific method includes a method of specifying by a qualitative analysis peak obtained by powder X-ray analysis. When specifying physical properties of a compound by a peak, it is preferable to specify by a main peak. Here, the main peak is one whose I / Io value is 30 or more, usually 50 or more, preferably 70 or more, more preferably 80 or more. Say. Here, I / Io is obtained by dividing the intensity value I of each peak by Io and multiplying it by 100 by setting the intensity value of the peak indicating the maximum intensity as Io. Here, the threshold value of I / Io for defining the main peak is not limited to the above, and can be arbitrarily determined according to the analysis result. Therefore, the I / Io threshold value may be set to any point as long as it is 100 or less, but can usually be any point between 30 and 100.

  The crystals of each intermediate of the present invention are stable and easy to handle, and are useful in the industrial production of carbapenem derivatives.

  As described above, the details of the present invention have been described in various forms. However, specific embodiments and examples in this specification are merely examples, and the scope of the present invention is not limited to specific examples. It is understood that the present invention is not limited in any way to the embodiments or examples.

(Example 1: Synthesis method of N-tert-butoxycarbonylsulfamide (Bocsulfamide, BSA))
(A: Liquid ammonia-method) (conventional method)
T-Butyl alcohol (32.7 kg) was added to ethyl acetate (626 L), cooled to −40 ° C., chlorosulfonyl isocyanate (62.5 kg) was added dropwise at −40 ± 10 ° C., and the mixture was stirred for 40 minutes. The reaction solution was cooled to −65 ° C., liquid ammonia (45.1 kg) was added dropwise at −60 ± 10 ° C., and the temperature was raised to 15 ± 10 ° C. To this reaction solution, 22% sulfuric acid (about 150 kg) was added to adjust the pH to 9.5 ± 1.0, and water (about 100 kg) was added and stirred for separation. The aqueous layer was washed with ethyl acetate (230 L), 22% sulfuric acid (about 170 kg) was added to adjust the pH to 2.0 ± 0.5, and the resulting BSA slurry was stirred at 7 ± 3 ° C. for 1 hour. Then, the crystals were filtered and dried to obtain 78.35 kg of BSA (yield: 90.4%).

(B: Ammonia water method) (method of the present invention)
Toluene (387 ml) was added with t-butyl alcohol (20.95 g), cooled to −0 ° C. or lower, chlorosulfonyl isocyanate (40.0 g) was added dropwise at −1 to −3 ° C., and the mixture was stirred for 20 minutes. Pyridine (49.2 g) was added dropwise thereto at 0 to −4 ° C., followed by stirring for 40 minutes. Further, 25% aqueous ammonia (114 g) was added dropwise at 0 to −4 ° C., water (32 g) was further added, and the mixture was stirred at −1 to 3 ° C. for 2.5 hours, and then allowed to stand overnight under ice cooling. The reaction solution was separated, the aqueous layer was washed with toluene (150 ml), each toluene layer was re-extracted with water (128 ml), and the aqueous layers were combined. The aqueous layer was adjusted to pH 2 by adding 22% aqueous sulfuric acid (271 g), and the resulting BSA slurry was stirred at 5 ° C. for 30 minutes, and then the crystals were filtered and dried to obtain 53.37 g of BSA ( Yield: 96.2%).
(Scheme 2)

（実施例２：（２Ｓ，４Ｒ）−４−ヒドロキシ−１−（４−ニトロベンジルオキシカルボニル）ピロリジン−２−カルボン酸（ＰＮＺ−プロリン、ＰＰＲ）の合成法）
水（６００ｍｌ）に水酸化ナトリウム（５３．６９ｇ）を溶解させた後氷冷し、これにＬ−ヒドロキシプロリン（８０．０ｇ）を加えて溶解させ、ＰＮＺ−Ｃｌ（１４４．６９ｇ）のトルエン（１６０ｍｌ）溶液を２〜６℃で滴下した後２℃で１時間攪拌した。反応液にトルエン（２４０ｍｌ）を加えて分液、水層はトルエン（１２０ｍｌ）で洗浄、各トルエン層は０．２％水酸化ナトリウム水溶液（２００ｍｌ）で再抽出した。水層を合わせ、酢酸エチル（８００ｍｌ）および３６％塩酸（８０．３３ｇ）を加えて抽出、酢酸エチル層は食塩水（２４０ｍｌ）で２回洗浄、各水層は酢酸エチル（２００ｍｌ）で再抽出した。酢酸エチル層を合併、濃縮と酢酸エチル（８００ｍｌ）追加を３回繰り返して脱水した。得られた濃縮液（４００ｇ）にトルエン（２７０ｍｌ）を加えて氷冷下１時間晶析後、結晶を濾過、乾燥してＰＰＲ １７６．１５ｇを得た（収率：９３．１％、融点１３３〜１３５℃）。

(Example 2: Synthesis method of (2S, 4R) -4-hydroxy-1- (4-nitrobenzyloxycarbonyl) pyrrolidine-2-carboxylic acid (PNZ-proline, PPR))
Sodium hydroxide (53.69 g) was dissolved in water (600 ml) and then ice-cooled. To this was added L-hydroxyproline (80.0 g) and dissolved, and PNZ-Cl (144.69 g) in toluene ( 160 ml) The solution was added dropwise at 2-6 ° C. and then stirred at 2 ° C. for 1 hour. Toluene (240 ml) was added to the reaction solution for separation, the aqueous layer was washed with toluene (120 ml), and each toluene layer was re-extracted with 0.2% aqueous sodium hydroxide solution (200 ml). The aqueous layers were combined, extracted by adding ethyl acetate (800 ml) and 36% hydrochloric acid (80.33 g), the ethyl acetate layer was washed twice with brine (240 ml), and each aqueous layer was re-extracted with ethyl acetate (200 ml). did. The ethyl acetate layers were combined, concentrated and dehydrated by repeating the addition of ethyl acetate (800 ml) three times. Toluene (270 ml) was added to the obtained concentrated liquid (400 g) and crystallized for 1 hour under ice-cooling. The crystals were filtered and dried to obtain 176.15 g of PPR (yield: 93.1%, melting point 133). ~ 135 ° C).

(Example 3: Synthesis method of 4-nitrobenzyl (2S, 4R) -2-hydroxymethyl-4-methylsulfonyloxypyrrolidine-1-carboxylate (pyrrolidine mesylate, PLM))
(A: Dichloromethane method (conventional method))
After adding PNZ-proline (31.0 kg) to dichloromethane (248 L), cool to −5 ± 5 ° C., add ethyl chlorocarbonate (11.9 kg), and add triethylamine (12.1 kg) dropwise at the same temperature. Stir for 25 minutes. Next, the mixture was cooled to −45 ± 5 ° C., methanesulfonyl chloride (12.6 kg) and triethylamine (12.1 kg) were added dropwise at the same temperature, and the mixture was stirred for 35 minutes. Next, isopropyl alcohol (78 kg) was added dropwise at −45 ± 5 ° C., and a solution of sodium borohydride (5.7 kg) in water (23 kg) was added dropwise at the same temperature, followed by stirring for 35 minutes. Next, the reaction solution was added to a 2.4% hydrochloric acid aqueous solution (234 kg), followed by liquid separation. The dichloromethane layer was washed with a 2% sodium hydrogen carbonate aqueous solution and 3% brine in this order, and each aqueous layer was re-extracted with dichloromethane (31 L). . The dichloromethane layers were combined and concentrated to 50 L, ethyl acetate (250 L) was added, and the mixture was concentrated to 110 L. Next, hexane (62 L) was added and crystallization ripening was performed at 3 ° C. for 1 hour, and then the crystals were filtered and dried to obtain 34.9 kg of PLM (yield: 93.3%).

(B: Tributylamine / ethyl acetate method)
PNZ-proline (5.00 g) and tributylamine (3.58 g) were added to ethyl acetate (40 ml) and then cooled to −35 ± 5 ° C., and ethyl chlorocarbonate (1.92 g) was added dropwise thereto at the same temperature. Stir for another hour. Next, the mixture was cooled to −45 ± 5 ° C., methanesulfonyl chloride (2.27 g) and triethylamine (2.61 g) were added dropwise at the same temperature, and the mixture was stirred for 1.5 hours. Next, isopropyl alcohol (16 ml) was added dropwise at −45 ± 5 ° C., and a solution of sodium borohydride (0.91 g) in water (3.6 ml) was added dropwise at the same temperature, followed by stirring for 30 minutes. Next, the reaction solution was added to a 3.3% sulfuric acid aqueous solution (42 g), followed by liquid separation. The ethyl acetate layer was washed with 3.3% sulfuric acid aqueous solution, 2% sodium hydrogen carbonate aqueous solution and 3% brine in this order. Re-extracted with ethyl acetate (10 ml). After the ethyl acetate layers were combined and concentrated, toluene (5 ml) was added and crystallization ripening was performed for 1 hour under ice cooling, and then the crystals were filtered and dried to obtain 2.54 g of PLM (yield: 84.2%). , Melting point 100-102 ° C).
(Scheme 3)

（実施例４：４−ニトロベンジル（２Ｓ，４Ｒ）−２−ヒドロキシメチル−４−メチルスルホニルオキシピロリジン−１−カルボキシラート（ピロリジンメシレート、ＰＬＭ）の合成法−メチルエステル経由法（低温反応回避））
（メチル（２Ｓ，４Ｒ）−４−ヒドロキシ−１−（４−ニトロベンジルオキシカルボニル）ピロリジン−２−カルボキシラート（メチルエステル体（１））の合成法）
メタノール（１２４ｍｌ）にＰＮＺ−プロリン（３１．０３ｇ）を加えた後、約２０℃で塩化チオニル（７．９９ｍｌ）を滴下し、同温度で３時間攪拌した。次に反応液を７％炭酸水素ナトリウム水溶液（５４０ｍｌ）に流入し、トルエン（１２４ｍｌ）および酢酸エチル（５００ｍｌ）で抽出した。有機層は水（２００ｍｌ）２回、飽和食塩水（２００ｍｌ）の順に洗浄後硫酸マグネシウムで脱水し、溶媒留去することによりメチルエステル体（１）を淡黄褐色油状物として３５．０６ｇ得た（収率：１００％）。

(Example 4: Synthesis method of 4-nitrobenzyl (2S, 4R) -2-hydroxymethyl-4-methylsulfonyloxypyrrolidine-1-carboxylate (pyrrolidine mesylate, PLM) -methyl ester via method (low-temperature reaction avoidance) ))
(Method for synthesizing methyl (2S, 4R) -4-hydroxy-1- (4-nitrobenzyloxycarbonyl) pyrrolidine-2-carboxylate (methyl ester (1)))
PNZ-proline (31.03 g) was added to methanol (124 ml), thionyl chloride (7.99 ml) was added dropwise at about 20 ° C., and the mixture was stirred at the same temperature for 3 hr. Next, the reaction solution was poured into 7% aqueous sodium hydrogen carbonate solution (540 ml) and extracted with toluene (124 ml) and ethyl acetate (500 ml). The organic layer was washed with water (200 ml) twice and saturated brine (200 ml) in this order, dehydrated with magnesium sulfate, and evaporated to give 35.06 g of methyl ester (1) as a pale tan oil. (Yield: 100%).

(Synthesis Method of Methyl (2S, 4R) -1- (4-nitrobenzyloxycarbonyl) -4-methylsulfonyloxypyrrolidine-2-carboxylate (MPRM))
The methyl ester product (1) (35.06 g) was dissolved in ethyl acetate (350 ml) and cooled to −10 ° C. Next, methanesulfonyl chloride (10.06 ml) and triethylamine (17.84 ml) were added dropwise at −10 to −5 ° C., followed by stirring at −5 ± 5 ° C. for 1 hour. The reaction solution was extracted by flowing into 1.4% aqueous sulfuric acid (170 ml). The organic layer was washed with water (170 ml), 1% aqueous sodium hydrogen carbonate solution (170 ml) and saturated brine (170 ml) in this order. Re-extracted with ethyl acetate (170 ml). The organic layers were combined and dried over magnesium sulfate, and then the solvent was distilled off. Toluene (150 ml) was added to the resulting slurry, followed by crystallization and filtration, followed by drying to obtain 36.92 g of MPRM as white crystals (yield). Rate: 91.8% (based on PPR)).

(Synthesis Method of 4-Nitrobenzyl (2S, 4R) -2-hydroxymethyl-4-methylsulfonyloxypyrrolidine-1-carboxylate (pyrrolidine mesylate, PLM))
MPRM (1.5 g) was dissolved in ethyl acetate (12 ml), NaBH ₄ (0.28 g) was added, and methanol (0.92 ml) was further added dropwise at 7 to 10 ° C., and then 6.5 to 5 to 10 ° C. Stir for hours. The reaction solution was extracted by flowing into 2% aqueous sulfuric acid (12.3 ml). The organic layer was washed with 1% aqueous sodium hydrogen carbonate solution (12 ml) and water (12 ml) twice in order, and each aqueous layer was ethyl acetate (10 ml). Re-extracted with The organic layers were combined and dried over anhydrous sodium sulfate, and then the solvent was distilled off. Toluene (4 ml) was added thereto, crystallization was followed by filtration and drying to obtain 1.31 g of PLM as crystals (yield: 94.1). %).
(Scheme 4)

この結晶について、理学電機株式会社製ＲＩＮＴ１１００を用いて以下の条件で粉末Ｘ線回折構造解析を行ったところ、図１のようなピークを示す結果を得た。管球：Ｃｕ、管電圧：４０ｋＶ、管電流：４０ｍＡ、ゴニオメータ：広角ゴニオメータ、サンプリング角度０．０２０°、スキャンスピード：２．００°／分、走査軸：２θ／θ、オフセット角度：０．０００°、アタッチメント：標準試料ホルダー、モノクロメータ：使用、モノクロ受光スリット：０．６０ｍｍ、発散スリット：１°、散乱スリット：１°、および受光スリット：０．１５ｍｍ。

When this powder was subjected to powder X-ray diffraction structure analysis under the following conditions using RINT1100 manufactured by Rigaku Corporation, a result showing a peak as shown in FIG. 1 was obtained. Tube: Cu, tube voltage: 40 kV, tube current: 40 mA, goniometer: wide-angle goniometer, sampling angle 0.020 °, scan speed: 2.00 ° / min, scan axis: 2θ / θ, offset angle: 0.000 °, attachment: standard sample holder, monochromator: use, monochrome light receiving slit: 0.60 mm, divergence slit: 1 °, scattering slit: 1 °, and light receiving slit: 0.15 mm.

FIG. 1 shows raw data of powder X-ray diffraction analysis in the upper stage, and shows the position and size of each peak in the lower stage. Furthermore, what was digitized about each peak is shown in FIG.
(Example 5: Synthesis method of 4-nitrobenzyl (2S, 4S) -4-acetylthio-2-hydroxymethylpyrrolidine-1-carboxylate (acetylthiopyrrolidine, ATP))
(A: DMF-toluene solvent)
After adding potassium thioacetate (16.0 kg), dimethylformamide (75 kg) and toluene (104 kg) to PLM (40.0 kg) to make a slurry, the temperature was raised to 65 ± 5 ° C. and stirred for 4 hours. After completion of the reaction, the mixture was extracted with ethyl acetate (540 kg) and water (300 kg), the organic layer was washed twice with 5% brine (200 kg), and each aqueous layer was re-extracted with ethyl acetate (110 kg). The ethyl acetate layers were combined and concentrated to 290 L, toluene (300 kg) was added, and the mixture was concentrated to 290 L. The obtained slurry was aged and crystallized overnight at 25 ± 10 ° C., and then the crystals were filtered and dried to obtain 27.9 kg of ATP (yield: 73.7%, melting point 130 to 132 ° C.).

This crystal was subjected to powder X-ray diffraction structure analysis under the same conditions as described in Example 4 using RINT1100, and results showing peaks as shown in FIG. 3 were obtained. The upper row shows raw data of powder X-ray diffraction analysis, and the lower row shows the position and size of each peak. Furthermore, what digitized about each peak is shown in FIG.
(B: CH ₃ CN- water solvent)
After adding potassium thioacetate (4.60 g), acetonitrile (22.5 ml) and water (1.5 ml) to PLM (7.5 g), the mixture was heated to 65 ° C. and stirred for 10 hours. After completion of the reaction, the mixture was extracted with ethyl acetate (113 ml) and water (30 ml), the organic layer was washed twice with 5% brine (37.5 ml), and each aqueous layer was re-extracted with ethyl acetate (52.5 ml). When the ethyl acetate layers were combined and quantified by HPLC, 5.59 g of ATP was produced (production rate: 80.7%).
(Scheme 5)

（実施例６：４−ニトロベンジル（２Ｓ，４Ｓ）−４−アセチルチオ−２−（Ｎ−スルファモイル−ｔｅｒｔ−ブトキシカルボキサミドメチル）ピロリジン−１−カルボキシラート（アセチルチオスルファミド、ＡＴＳ）の合成法）
ＡＴＰ（１００．０ｇ）にトリフェニルホスフィン（９０．２ｇ）、ＢＳＡ（８３．０ｇ）および酢酸エチル（２．４Ｌ）を加えてスラリー化した後、２０℃以下でジイソプロピルアゾジカルボン酸（ＤＩＡＤ）（６８．３ｇ）を滴下した。１８〜２１℃で２時間攪拌した後濃縮、メタノール（０．５Ｌ）を加えて濃縮、再度メタノール（０．５Ｌ）を加えて濃縮した後メタノールで液量を７００ｇに調整した。この溶液を６５℃に加熱し水（７５ｇ）を加えた後、５０℃で２時間攪拌して晶析、さらに室温で１晩放置後、結晶を濾過し、乾燥してＡＴＳ １２１．６８ｇを得た（収率：８１．０％、融点１３３〜１３６℃：ＩＲ（ＫＢｒ） ３３６１，３２２６，２９７８，１７０８，１６９２，１５２３，１３８１，１３３６，１１８７，１１４９ ｃｍ^-1；¹Ｈ−ＮＭＲ（ＣＤＣｌ₃）δ １．４８（ｓ，９Ｈ），１．５７−１．６１（ｄｄｄ，１Ｈ，Ｊ＝１４．１Ｈｚ，Ｊ＝５．４Ｈｚ，Ｊ＝３．６Ｈｚ），２．３５（ｓ，３Ｈ），２．５９（ｄｔ，１Ｈ，Ｊ＝１４．１Ｈｚ，Ｊ＝８．６Ｈｚ），３．２７（ｄｄ，１Ｈ，Ｊ＝１２．１Ｈｚ，Ｊ＝６．５Ｈｚ），３．６２（ｄｄ，１Ｈ，Ｊ＝１４．９Ｈｚ，Ｊ＝２．７Ｈｚ），３．９６（ｍ，１Ｈ），４．０２（ｄｄ，１Ｈ，Ｊ＝１４．９Ｈｚ，Ｊ＝８．５Ｈｚ），４．２７（ｄｄ，１Ｈ，Ｊ＝１２．１Ｈｚ，Ｊ＝７．８Ｈｚ），４．５５（ｍ，１Ｈ），５．１８（ＡＢｑ，２Ｈ，Ｊ＝１３．４Ｈｚ），５．８６（ｂｒ，２Ｈ），７．４９（Ａ₂Ｂ₂，２Ｈ，Ｊ＝８．７Ｈｚ），８．２４（Ａ₂Ｂ₂，２Ｈ，Ｊ＝８．７Ｈｚ）；¹³Ｃ−ＮＭＲ（ＣＤＣｌ₃）δ ２８．０９，３０．５１，３４．４６，３９．１５，４９．９３，５２．１７，５６．７２，６６．１１，８４．１５，１２３．９１，１２８．１９，１４３．１０，１４７．８１，１５１．８１，１５５．１０，１９４．８５；ＦＡＢＭＳ ｍ／ｚ ５３３ ［Ｍ＋Ｈ］⁺，５５５ ［Ｍ＋Ｎａ］⁺）。
（スキーム６）

Example 6: Synthesis method of 4-nitrobenzyl (2S, 4S) -4-acetylthio-2- (N-sulfamoyl-tert-butoxycarboxamidomethyl) pyrrolidine-1-carboxylate (acetylthiosulfamide, ATS) )
To ATP (100.0 g), triphenylphosphine (90.2 g), BSA (83.0 g) and ethyl acetate (2.4 L) were added to form a slurry, followed by diisopropyl azodicarboxylic acid (DIAD) (20 ° C. or lower). 68.3 g) was added dropwise. The mixture was stirred at 18 to 21 ° C. for 2 hours, concentrated, concentrated by adding methanol (0.5 L), concentrated again by adding methanol (0.5 L), and the liquid volume was adjusted to 700 g with methanol. This solution was heated to 65 ° C., water (75 g) was added, and the mixture was stirred at 50 ° C. for 2 hours for crystallization. After standing overnight at room temperature, the crystals were filtered and dried to obtain 121.68 g of ATS. (Yield: 81.0%, melting point 133-136 ° C .: IR (KBr) 3361, 3226, 2978, 1708, 1692, 1523, 1381, 1336, 1187, 1149 cm ⁻¹ ; ¹ H-NMR (CDCl ₃ ) Δ 1.48 (s, 9H), 1.57-1.61 (ddd, 1H, J = 14.1 Hz, J = 5.4 Hz, J = 3.6 Hz), 2.35 (s, 3H) , 2.59 (dt, 1H, J = 14.1 Hz, J = 8.6 Hz), 3.27 (dd, 1H, J = 12.1 Hz, J = 6.5 Hz), 3.62 (dd, 1H) , J = 14.9 Hz, J = 2.7 Hz), 3.96 (m, 1H), 4.02 (dd, 1H, J = 14.9 Hz, J = 8.5 Hz), 4.27 (dd, 1H, J = 12.1 Hz, J = 7.8 Hz), 4.55 (m, 1H) 5.18 (ABq, 2H, J = 13.4 Hz), 5.86 (br, 2H), 7.49 (A ₂ B ₂ , 2H, J = 8.7 Hz), 8.24 (A ₂ B ₂ , 2H, J = 8.7 Hz); ¹³ C-NMR (CDCl ₃ ) δ 28.09, 30.51, 34.46, 39.15, 49.93, 52.17, 56.72, 66. 11, 84.15, 123.91, 128.19, 143.10, 147.81, 151.81, 155.10, 194.85; FABMS m / z 533 [M + H] ⁺ , 555 [M + Na] ⁺ ) .
(Scheme 6)

この結晶について、ＲＩＮＴ１１００を用いて実施例４に記載のものと同一の条件で粉末Ｘ線回折構造解析を行ったところ、図５のようなピークを示す結果を得た。上段は、粉末Ｘ線回折解析の生データを示し、下段は各ピークの位置および大きさを示す。さらに、各ピークについて数値化したものを図６に示す。

This crystal was subjected to powder X-ray diffraction structure analysis under the same conditions as described in Example 4 using RINT1100, and results showing peaks as shown in FIG. 5 were obtained. The upper row shows raw data of powder X-ray diffraction analysis, and the lower row shows the position and size of each peak. Furthermore, what digitized about each peak is shown in FIG.

  Further, a three-dimensional view of ATS single crystal X-ray crystal structure analysis is shown below.

（実施例７：４−ニトロベンジル（２Ｓ，４Ｓ）−４−メルカプト−２−スルファモイルアミノメチルピロリジン−１−カルボキシラート（チオールピロリジン、ＳＰＬ）の合成法）
（１）
アセチルチオスルファミド（１８．３ｋｇ）にメタノール（７２．３ｋｇ）およびメタンスルホン酸（１．６５ｋｇ）を加えて６５±５℃で７．７時間攪拌した。反応液を２５℃以下に冷却した後、減圧下、溶媒留去して約５０Ｌまで濃縮した。濃縮液を酢酸エチル（１２５ｋｇ）と水（１３６ｋｇ）の混合液に流入して抽出、有機層は５％食塩水（９４ｋｇ）で３回洗浄、各水層は酢酸エチル（５５ｋｇ）で再抽出し、有機層を合併した。この有機層を減圧下、溶媒留去して約３４ｋｇまで濃縮し、さらに酢酸エチル（９８ｋｇ）を加えて減圧下、再び溶媒留去して約３４ｋｇまで濃縮してＳＰＬ／酢酸エチル溶液を得た。
スキーム７

(Example 7: Synthesis method of 4-nitrobenzyl (2S, 4S) -4-mercapto-2-sulfamoylaminomethylpyrrolidine-1-carboxylate (thiolpyrrolidine, SPL))
(1)
Methanol (72.3 kg) and methanesulfonic acid (1.65 kg) were added to acetylthiosulfamide (18.3 kg), and the mixture was stirred at 65 ± 5 ° C. for 7.7 hours. After cooling the reaction solution to 25 ° C. or lower, the solvent was distilled off under reduced pressure and concentrated to about 50 L. The concentrated solution was extracted by flowing into a mixed solution of ethyl acetate (125 kg) and water (136 kg), the organic layer was washed 3 times with 5% saline (94 kg), and each aqueous layer was re-extracted with ethyl acetate (55 kg). , Merged the organic layer. The organic layer was evaporated under reduced pressure to concentrate to about 34 kg, further ethyl acetate (98 kg) was added, and the solvent was distilled off again under reduced pressure to concentrate to about 34 kg to obtain an SPL / ethyl acetate solution. .
Scheme 7

（２）
アセチルチオスルファミド（１３４．４ｇ）にメタノール（６７２ｍｌ）および９８％硫酸（６３．２ｇ）を加えて６５±５℃で２時間攪拌した後、減圧下、溶媒留去した。濃縮液を酢酸エチル（１０６７ｍｌ）と水（９３３ｍｌ）の混合液に流入して抽出、有機層は５％食塩水（７００ｍｌ）で３回洗浄、各水層は酢酸エチル（４００ｍｌ）で再抽出し、有機層を合併した。この有機層を減圧下、溶媒留去、さらに酢酸エチル（８００ｍｌ）を加えて減圧下、再び溶媒留去してＳＰＬ／酢酸エチル溶液２８０ｇを得た。

(2)
Methanol (672 ml) and 98% sulfuric acid (63.2 g) were added to acetylthiosulfamide (134.4 g), and the mixture was stirred at 65 ± 5 ° C. for 2 hours, and then the solvent was distilled off under reduced pressure. The concentrated solution was extracted by flowing into a mixed solution of ethyl acetate (1067 ml) and water (933 ml), the organic layer was washed 3 times with 5% brine (700 ml), and each aqueous layer was re-extracted with ethyl acetate (400 ml). , Merged the organic layer. The organic layer was evaporated under reduced pressure, further ethyl acetate (800 ml) was added, and the solvent was evaporated again under reduced pressure to obtain 280 g of an SPL / ethyl acetate solution.

Example 8 Synthesis Method of Compound A
(1) 4-nitrobenzyl (4R, 5S, 6S) -6-[(1R) -1-hydroxyethyl] -4-methyl-3-[[(3S, 5S) -1- (4-nitrobenzyloxy Carbonyl) -5- (sulfamoylaminomethyl) pyrrolidin-3-yl] thio] -7-oxo-1-azabicyclo [3.2.0] hept-2-en-2-carboxylate (thiopyrrolidine carbapenem ester , TCE) synthesis method (extraction method)
Enol phosphate (120.0 g) and dimethylformamide (600 ml) were added to an SPL / ethyl acetate solution (280 g), and the mixture was ice-cooled. Diisopropylethylamine (36.4 g) was added, and the mixture was reacted at 5 ° C. or lower overnight. This reaction solution was extracted by flowing into a mixed solution of ethyl acetate (900 ml) and water (900 ml), and the organic layer was 0.7% hydrochloric acid aqueous solution (612 g), 5% aqueous sodium hydrogen carbonate solution (252 g), 5% brine. Washing in order of (360 g × 2 times), each aqueous layer was re-extracted with ethyl acetate (400 ml), and the organic layers were combined. The organic layer was evaporated under reduced pressure and concentrated to 740 g, methanol (222.5 ml) and TCE seed crystals were added and crystallized at 25 ° C. for 65 minutes, and methanol (1157 ml) was further added at room temperature. Crystallized for 60 minutes. The obtained crystals were filtered and dried to obtain 142.18 g of TCE (yield: 95.9%).

  This crystal was subjected to powder X-ray diffraction structural analysis using RINT1100 under the same conditions as those described in Example 4. As a result, a peak having a peak as shown in FIG. 7 was obtained. The upper row shows raw data of powder X-ray diffraction analysis, and the lower row shows the position and size of each peak. Furthermore, what digitized about each peak is shown in FIG.

(Direct crystallization method)
Enol phosphate (5.0 g) and acetonitrile (20 ml) are added to an SPL / ethyl acetate solution (11.7 g, equivalent to ATS 5.60 g), and ice-cooled. Diisopropylethylamine (1.52 g) is further added to 5 ° C. or less. And reacted overnight. Methanol (60 ml) and TCE seed crystals were added to this reaction solution while maintaining the temperature at 2 ° C. or lower, and crystallization was carried out at 0 to 2 ° C. for 1 hour. The crystals were filtered and dried to obtain 4.42 g of TCE. (Yield: 71.5%).

  This crystal was subjected to powder X-ray diffraction structure analysis under the same conditions as described in Example 4 using RINT1100, and the result showing the peak as shown in FIG. 9 was obtained. The upper row shows raw data of powder X-ray diffraction analysis, and the lower row shows the position and size of each peak. Furthermore, what digitized about each peak is shown in FIG.

(2) (4R, 5S, 6S) -6-[(1R) -1-hydroxyethyl] -4-methyl-7-oxo-3-[[(3S, 5S) -5- (sulfamoylaminomethyl) ) Synthesis method of pyrrolidin-3-yl] thio] -1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid (Compound A) Tetrahydrofuran (60 L) was added to TCE (10.0 kg). After adding ion-exchanged water (40 kg), 10% Pd-C (5.0 kg) and magnesium chloride hexahydrate (1.4 kg) to this, hydrogen gas was introduced and 0.5 MPa was added. The mixture was stirred at 26-38 ° C. for 2 hours under pressure. The reaction solution was filtered, and Pd—C was washed with a mixed solution of tetrahydrofuran (18 L) -ion exchanged water (12 L) and merged with the filtrate. To this, magnesium chloride hexahydrate (0.7 kg) was added and dissolved. Further, tetrahydrofuran (300 L) was added, and the lower layer was separated at 26 ± 2 ° C. The obtained lower layer was cooled to 0 ± 5 ° C., and methanol (40 L) and seed crystals (10 g) of compound A were added to crystallize compound A. On the other hand, the operation of adding magnesium chloride hexahydrate (0.7 kg) to the upper layer after liquid separation and liquid-separating the lower layer was further repeated twice, and the obtained lower layer was merged with the slurry of Compound A sequentially. Methanol (75 L) was further introduced into this, and crystallization was aged at 0 ± 5 ° C. for 1 hour and further at −10 ± 5 ° C. for 1 hour, and then the crystals were filtered and dried to obtain 3.84 kg of crude compound A. (Yield: 67.1%).

(3) Purification of Compound A Crude Compound A (3.30 kg) was added to ion-exchanged water (66.0 kg), dissolved by heating to about 55 ° C., and this solution was treated with activated carbon (0 The filter was passed through a filter pre-coated with 0.1 kg), a 0.2 μm membrane filter, an ultrafiltration membrane and a sterile filtration filter in this order. The filtrate was cooled to 24 to 18 ° C., stirred for 30 minutes to precipitate crystals, further cooled to 2 ± 3 ° C. and aged for 2 hours. After isopropyl alcohol (26.1 kg) filtered through a sterile filter was poured into this over 1 hour and 20 minutes, crystallization and aging were carried out at −3 to −7 ° C. for 4 hours and further at −10 to −13 ° C. overnight. The crystals were collected by filtration. The obtained crystals were mixed with isopropyl alcohol (4.17 kg) and ion-exchanged water (1.32 kg), washed with 80% isopropyl alcohol water filtered through a sterile filter, and then dried under reduced pressure at 60 ° C. for 18 hours. A 2.89 kg was obtained (yield 87.5%).
Scheme 8

して約２．５ｇまで濃縮してＴＣＥ／酢酸エチル溶液を得た。この溶液を０℃に冷却し、ジメチルホルムアミド（２ｍｌ）およびメタノール（１０ｍｌ）を加（実施例９：アモルファスＴＣＥの合成）
（１）４−ニトロベンジル（２Ｓ，４Ｓ）−４−メルカプト−２−スルファモイルアミノエチルピロリジン−１−カルボキシレート（チオールピロリジン、ＳＰＬ）の合成
アセチルチオスルファミド（３３．６ｋｇ）にメタノール（１４０．０ｋｇ）および９８％精製硫酸（１５．８ｋｇ）を加えて６５±５℃で２．０±０．５時間攪拌した。反応液を減圧下、溶媒留去して約１１０Ｌにまで濃縮した。濃縮液を酢酸エチル（２２５ｋｇ）と水（２５０ｋｇ）との混合液に流入して抽出し、有機層を５％食塩水（１７５ｋｇ）で３回洗浄、各水層を酢酸エチル（９０ｋｇ）で再抽出し、有機層を合併した。この有機層を減圧下、溶媒留去して約７０ｋｇまで濃縮し、さらに酢酸エチル（１８０ｋｇ）を加えて減圧下、再び溶媒留去して約７０ｋｇまで濃縮してＳＰＬ／酢酸エチル溶液を得た。

And concentrated to about 2.5 g to obtain a TCE / ethyl acetate solution. The solution was cooled to 0 ° C. and dimethylformamide (2 ml) and methanol (10 ml) were added (Example 9: Synthesis of amorphous TCE)
(1) Synthesis of 4-nitrobenzyl (2S, 4S) -4-mercapto-2-sulfamoylaminoethylpyrrolidine-1-carboxylate (thiolpyrrolidine, SPL) Methanol was added to acetylthiosulfamide (33.6 kg). (140.0 kg) and 98% purified sulfuric acid (15.8 kg) were added and stirred at 65 ± 5 ° C. for 2.0 ± 0.5 hours. The reaction solution was concentrated to about 110 L by distilling off the solvent under reduced pressure. The concentrated solution was extracted by flowing into a mixture of ethyl acetate (225 kg) and water (250 kg), and the organic layer was washed 3 times with 5% brine (175 kg), and each aqueous layer was re-washed with ethyl acetate (90 kg). Extract and merge the organic layers. The organic layer was evaporated under reduced pressure to concentrate to about 70 kg, and further ethyl acetate (180 kg) was added. Under reduced pressure, the solvent was evaporated again and concentrated to about 70 kg to obtain an SPL / ethyl acetate solution. .

(2) 4-nitrobenzyl (4R, 5S, 6S) -6-[(1R) -1-hydroxyethyl] -4-methyl-3-[[(3S, 5S) -1- (4-nitrobenzyloxy Carbonyl) -5- (sulfamoylaminoethyl) pyrrolidin-3-yl] thio] -7-oxo-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylate (thiopyrrolidine carbapenem ester , TCE) Enol phosphate (30.0 kg) and dimethylformamide (143 kg) were added to an SPL / ethyl acetate solution (about 70 kg), cooled to 0 ± 5 ° C., and diisopropylethylamine (9.1 kg) was further added. The mixture was stirred at 0 ± 5 ° C. for 18 ± 4 hours. Ethyl acetate (200 kg) and water (225 kg) were poured into this reaction solution for extraction, and the organic layer was extracted with 0.7% hydrochloric acid aqueous solution (153 kg), 5% aqueous sodium hydrogen carbonate solution (63 kg), 5% brine (90 kg). Washed in the order of × 2), each aqueous layer was re-extracted with ethyl acetate (90 kg), and the organic layers were combined. The organic layer was evaporated to a concentration of about 104 L under reduced pressure, and further ethyl acetate (180 kg) was added. Under reduced pressure, the solvent was evaporated to a concentration of about 104 L, and further ethyl acetate (180 kg) was added. Under reduced pressure, the solvent was distilled off and concentrated to about 155 L. This TCE / ethyl acetate solution was poured into toluene (365 kg) over about 30 minutes, and the obtained TCE slurry was filtered and dried to obtain 36.6 kg of TCE as a pale yellow powder (yield: 98.7%). ).

(Example 10)
(Synthesis of TCE without isolation of ELP-PNB)
(1) Synthesis method of 4-nitrobenzyl (2S, 4S) -4-mercapto-2-sulfamoylaminomethylpyrrolidine-1-carboxylate (thiolpyrrolidine, SPL) To acetylthiosulfamide (1.08 g) Methanol (5.4 ml) and concentrated sulfuric acid (0.20 g) were added and stirred at 65 ± 5 ° C. for 7 hours. The reaction solution was cooled to 25 ° C. or lower, extracted by flowing into a mixed solution of ethyl acetate (8.2 ml) and water (8 ml), and the organic layer was washed 3 times with 5% brine (5.5 ml). The aqueous layer was re-extracted with ethyl acetate (3.3 ml) and the organic layers were combined. After the solvent was distilled off from the organic layer under reduced pressure, ethyl acetate (5 ml) was further added, and the solvent was distilled off again under reduced pressure to concentrate to about 2.2 g to obtain an SPL / ethyl acetate solution.

(2) 4-nitrobenzyl (4R, 5S, 6S) -6-[(1R) -1-hydroxyethyl] -4-methyl-3-[[(3S, 5S) -1- (4-nitrobenzyloxy Carbonyl) -5- (sulfamoylaminomethyl) pyrrolidin-3-yl] thio] -7-oxo-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylate (thiopyrrolidine carbapenem ester , TCE) (A) Acetonitrile Method Acetonitrile method (609 mg) with acetonitrile (2.4 ml) added and cooled to −30 ° C., diphenylphosphorochloridate (0.43 g) and diisopropylethylamine (0.22 g) After stirring at 0 ° C. for 2 hours, dimethylformamide (3 ml) and SPL / ethyl acetate solution (about 2.2 g), diiso B were added and stirred pill ethylamine (0.26 g) at 5 ° C. or less 16 hours. The reaction solution was separated by flowing into a mixture of ethyl acetate (13 ml) and 5% brine (6.1 ml), and the organic layer was washed twice with 5% brine (6.1 ml). Re-extracted with ethyl acetate (13 ml) and combined organic layers. After the solvent was distilled off from the organic layer under reduced pressure, ethyl acetate (6 ml) was further added, and the solvent was distilled off again under reduced pressure to concentrate to about 2.5 g to obtain a TCE / ethyl acetate solution. The solution was cooled to 0 ° C., dimethylformamide (2 ml) and methanol (15 ml) were added, then TCE seed crystals (10 mg) were added, and the crystals were crystallized at 0 ± 5 ° C. for 1 hour and −10 ± 5 ° C. for 4 hours. After the analysis, the crystals were filtered and dried to obtain 807 mg of TCE (yield: 70.5%).

(B) Dimethylformamide method Dimethylphosphorochloridate (0.43 g) and diisopropylethylamine (0.22 g) were added to a ketone body (609 mg) by adding dimethylformamide (3 ml) and cooling to -30 ° C. After stirring for 2 hours, the mixture was mixed with an SPL / ethyl acetate solution (about 2.2 g), diisopropylethylamine (0.26 g) was further added, and the mixture was stirred at 5 ° C. or lower for 16 hours. The reaction solution was separated by flowing into a mixed solution of ethyl acetate (13 ml) and water (6.1 ml), the organic layer was washed twice with 5% brine (6.1 ml), and each aqueous layer was washed with ethyl acetate (6.1 ml). 13 ml), and the organic layers were combined. After the solvent was distilled off under reduced pressure, ethyl acetate (6 ml) was further added and the solvent was distilled off again under reduced pressure. Then, TCE seed crystals (10 mg) were added, and the mixture was added at 0 ± 5 ° C. for 1 hour. After crystallization at 10 ± 5 ° C. for 3 hours, the crystals were filtered and dried to obtain 910 mg of TCE (yield: 73.7%).
Scheme 9

（実施例１１：アセチルチオピロリジン（ＡＴＰ）の合成法）
（ＭＰＲＭ（メシル体（２））の直接合成法）
Ａ）塩化チオニル法
メタノール（５０ｍｌ）にＬ−ヒドロキシプロリン（１０．０ｇ）を加えて冷却し、塩化チオニル（９．９８ｇ）を０〜１０℃で滴下した後、４０℃で２時間攪拌した。反応液を冷却後、４８％水酸化ナトリウム水溶液（６．９９ｇ）を０〜１０℃で滴下した。冷水道水（３０ｍｌ）を加えて冷却し、炭酸カリウム（１５．８１ｇ）を０〜２０℃で発泡に注意しながら加えた。再び冷却後、５３％ＰＮＺ−Ｃｌトルエン溶液（３１．０２ｇ）を０〜５℃で滴下し、０〜５℃で１時間攪拌した。反応液を濃縮後、酢酸エチル（１００ｍｌ）、水道水（６０ｍｌ）を加えて分液し、有機層を濃縮した。濃縮液にトルエン（１００ｍｌ）を加えて濃縮した後、再度トルエン（１００ｍｌ）を加え、１０〜２０℃でトリエチルアミン（９．２６ｇ）を加えた。塩化メタンスルホニル（９．６１ｇ）を１２〜３２℃で滴下した後、水道水（６０ｍｌ）を加えて晶析後、ろ過、乾燥してＭＰＲＭを結晶として２７．８ｇ得た（収率：９０．６％）。
Ｂ）オキシ塩化リン法
メタノール（５０ｍｌ）にＬ−ヒドロキシプロリン（１０．０ｇ）を加えて冷却し、オキシ塩化リン（５．８５ｇ）を０〜２０℃で滴下した後６０℃で２時間攪拌した。反応液を冷却後、４８％水酸化ナトリウム水溶液（３．１８ｇ）を０〜１０℃で滴下した。冷水道水（４０ｍｌ）を加えて冷却し、炭酸カリウム（１５．８１ｇ）を０〜２０℃で発泡に注意しながら加えた。再び冷却後、５３％ＰＮＺ−Ｃｌトルエン溶液（３１．０２ｇ）を０〜５℃で滴下し、０〜５℃で１時間攪拌した。反応液を濃縮後、酢酸エチル（１００ｍｌ）、水道水（５０ｍｌ）を加えて分液し、有機層を濃縮した。濃縮液にトルエン（１００ｍｌ）を加えて濃縮した後、再度トルエン（１００ｍｌ）を加え、１０〜２０℃でトリエチルアミン（９．２６ｇ）を加えた。塩化メタンスルホニル（９．６１ｇ）を１０〜３０℃で滴下した後、水道水（６０ｍｌ）を加えて晶析後、ろ過、乾燥してＭＰＲＭを結晶として２６．１ｇ得た（収率：８５．０％）。
Ｃ）塩酸ガス法
１２．５％メタノール−塩酸ガス溶液（３８．９ｇ）にＬ−ヒドロキシプロリン（５．０ｇ）を０〜２０℃で加え、室温（２５±５℃）で３時間攪拌した。反応液を冷却後、４８％水酸化ナトリウム水溶液（７．３３ｇ）を０〜１０℃で滴下した。約３０ｍｌまで濃縮後、冷水道水（４０ｍｌ）を加えて冷却し、炭酸カリウム（８．４３ｇ）を０〜２０℃で発泡に注意しながら加えた。再び冷却後、５３％ＰＮＺ−Ｃｌトルエン溶液（３１．０２ｇ）を０〜５℃で滴下し、０〜５℃で１時間攪拌した。反応液を濃縮後、酢酸エチル（５０ｍｌ）、水道水（３０ｍｌ）を加えて分液し、有機層を濃縮した。濃縮液にトルエン（５０ｍｌ）を加えて濃縮した後、再度トルエン（５０ｍｌ）を加え、１０〜２０℃でトリエチルアミン（４．６３ｇ）を加えた。塩化メタンスルホニル（４．８０ｇ）を１０〜３０℃で滴下した後、水道水（３０ｍｌ）を加えて晶析後、ろ過、乾燥してＭＰＲＭを結晶として１３．２ｇ得た（収率：８５．９％）。
Ｄ）合成塩酸（３５％塩酸）法
メタノール（５０ｍｌ）にＬ−ヒドロキシプロリン（１０．０ｇ）を加え、合成塩酸（１０．８ｇ）を流入し６０℃で８時間攪拌後、室温（２５±５℃）で一晩（約１５時間）放置した。反応液を冷却後、４８％水酸化ナトリウム水溶液（３．１４ｇ）を０〜１０℃で滴下した。冷水道水（３０ｍｌ）を加えて冷却し、炭酸カリウム（１５．８１ｇ）を０〜２０℃で発泡に注意しながら加えた。再び冷却後、５３％ＰＮＺ−Ｃｌトルエン溶液（３１．０２ｇ）を０〜５℃で滴下し、０〜５℃で１時間攪拌した。反応液を濃縮後、酢酸エチル（１００ｍｌ）、水道水（６０ｍｌ）を加えて分液した。（有機層定量生成率：９５％）
（スキーム１０）

(Example 11: Synthesis method of acetylthiopyrrolidine (ATP))
(Direct synthesis method of MPRM (mesyl body (2)))
A) Thionyl chloride method L-hydroxyproline (10.0 g) was added to methanol (50 ml) and cooled, and thionyl chloride (9.98 g) was added dropwise at 0 to 10 ° C, followed by stirring at 40 ° C for 2 hours. After cooling the reaction solution, a 48% aqueous sodium hydroxide solution (6.99 g) was added dropwise at 0 to 10 ° C. Cold tap water (30 ml) was added and cooled, and potassium carbonate (15.81 g) was added at 0-20 ° C., taking care not to foam. After cooling again, a 53% PNZ-Cl toluene solution (31.02 g) was added dropwise at 0 to 5 ° C., and the mixture was stirred at 0 to 5 ° C. for 1 hour. After the reaction solution was concentrated, ethyl acetate (100 ml) and tap water (60 ml) were added for liquid separation, and the organic layer was concentrated. Toluene (100 ml) was added to the concentrate for concentration, toluene (100 ml) was added again, and triethylamine (9.26 g) was added at 10 to 20 ° C. Methanesulfonyl chloride (9.61 g) was added dropwise at 12 to 32 ° C., and tap water (60 ml) was added for crystallization, followed by filtration and drying to obtain 27.8 g of MPRM as crystals (yield: 90. 6%).
B) Phosphorus oxychloride method L-hydroxyproline (10.0 g) was added to methanol (50 ml) and the mixture was cooled. Phosphorus oxychloride (5.85 g) was added dropwise at 0 to 20 ° C, followed by stirring at 60 ° C for 2 hours. . After cooling the reaction solution, a 48% aqueous sodium hydroxide solution (3.18 g) was added dropwise at 0 to 10 ° C. Cold tap water (40 ml) was added and cooled, and potassium carbonate (15.81 g) was added at 0-20 ° C., taking care to avoid foaming. After cooling again, a 53% PNZ-Cl toluene solution (31.02 g) was added dropwise at 0 to 5 ° C., and the mixture was stirred at 0 to 5 ° C. for 1 hour. After concentrating the reaction solution, ethyl acetate (100 ml) and tap water (50 ml) were added for liquid separation, and the organic layer was concentrated. Toluene (100 ml) was added to the concentrate for concentration, toluene (100 ml) was added again, and triethylamine (9.26 g) was added at 10 to 20 ° C. Methanesulfonyl chloride (9.61 g) was added dropwise at 10 to 30 ° C., and tap water (60 ml) was added for crystallization, followed by filtration and drying to obtain 26.1 g of MPRM as crystals (yield: 85. 0%).
C) Hydrochloric acid gas method L-hydroxyproline (5.0 g) was added to a 12.5% methanol-hydrochloric acid gas solution (38.9 g) at 0 to 20 ° C., and the mixture was stirred at room temperature (25 ± 5 ° C.) for 3 hours. After cooling the reaction solution, a 48% aqueous sodium hydroxide solution (7.33 g) was added dropwise at 0 to 10 ° C. After concentrating to about 30 ml, cold tap water (40 ml) was added and cooled, and potassium carbonate (8.43 g) was added at 0 to 20 ° C. while paying attention to foaming. After cooling again, a 53% PNZ-Cl toluene solution (31.02 g) was added dropwise at 0 to 5 ° C., and the mixture was stirred at 0 to 5 ° C. for 1 hour. After concentrating the reaction solution, ethyl acetate (50 ml) and tap water (30 ml) were added for liquid separation, and the organic layer was concentrated. Toluene (50 ml) was added to the concentrate for concentration, toluene (50 ml) was added again, and triethylamine (4.63 g) was added at 10 to 20 ° C. Methanesulfonyl chloride (4.80 g) was added dropwise at 10 to 30 ° C., and tap water (30 ml) was added for crystallization, followed by filtration and drying to obtain 13.2 g of MPRM as crystals (yield: 85. 9%).
D) Synthetic hydrochloric acid (35% hydrochloric acid) method L-hydroxyproline (10.0 g) was added to methanol (50 ml), synthetic hydrochloric acid (10.8 g) was added, and the mixture was stirred at 60 ° C. for 8 hours, and then room temperature (25 ± 5 C.) overnight (about 15 hours). After cooling the reaction solution, a 48% aqueous sodium hydroxide solution (3.14 g) was added dropwise at 0 to 10 ° C. Cold tap water (30 ml) was added and cooled, and potassium carbonate (15.81 g) was added at 0-20 ° C., taking care not to foam. After cooling again, a 53% PNZ-Cl toluene solution (31.02 g) was added dropwise at 0 to 5 ° C., and the mixture was stirred at 0 to 5 ° C. for 1 hour. After concentrating the reaction solution, ethyl acetate (100 ml) and tap water (60 ml) were added for liquid separation. (Quantitative organic layer production rate: 95%)
(Scheme 10)

（アセチルチオピロリジン（ＡＴＰ）の合成法）
Ａ）ＡＴＰ抽出省略法
メシル体（２）（２７．５５ｇ）に酢酸エチル（１２０ｍｌ）およびメタノール（１６．５ｍｌ）を加え、３４℃に加温して溶解させた後冷却した。０〜５℃でＮａＢＨ₄（１３．２ｇ）を２時間かけて加え、さらに０〜５℃で３時間攪拌した。反応液を５％硫酸水（１３８ｍｌ）に流入して抽出、有機層を５％食塩水（５５ｍｌ）で２回洗浄した後、濃縮した。濃縮液ににチオ酢酸カリウム（１０．１７ｇ）、ジメチルホルムアミド（５０ｍｌ）および酢酸エチル（６６ｍｌ）を加えた後、６５±５℃に昇温し、８時間攪拌した。反応液を３０℃以下に冷却し、水道水（４４ｍｌ）および５％硫酸水溶液（１１ｍｌ）を加え、溶媒留去して晶析後、ろ過、乾燥してＡＴＰを結晶として１８．４ｇ得た（収率：７５．８％）。

(Method of synthesizing acetylthiopyrrolidine (ATP))
A) ATP extraction omission method Ethyl acetate (120 ml) and methanol (16.5 ml) were added to the mesyl derivative (2) (27.55 g), and the mixture was heated to 34 ° C. for dissolution and then cooled. NaBH ₄ (13.2 g) was added at 0 to 5 ° C. over 2 hours, and the mixture was further stirred at 0 to 5 ° C. for 3 hours. The reaction solution was extracted by flowing into 5% aqueous sulfuric acid (138 ml), and the organic layer was washed twice with 5% brine (55 ml) and concentrated. To the concentrated solution were added potassium thioacetate (10.17 g), dimethylformamide (50 ml) and ethyl acetate (66 ml), and then the mixture was heated to 65 ± 5 ° C. and stirred for 8 hours. The reaction solution was cooled to 30 ° C. or lower, tap water (44 ml) and 5% aqueous sulfuric acid solution (11 ml) were added, the solvent was distilled off, crystallized, filtered and dried to obtain 18.4 g of ATP as crystals ( Yield: 75.8%).

B) ATP extraction method Ethyl acetate (20 ml) and methanol (3 ml) were added to the mesyl derivative (2) (5.00 g), and the mixture was heated to 36 ° C and dissolved, and then cooled. A suspension of NaBH ₄ (0.94 g) in ethyl acetate (5 ml) was added over 2 hours at 0 to 5 ° C., and the mixture was further stirred at 0 to 5 ° C. for 4 hours. The reaction solution was extracted by flowing into 5% aqueous sulfuric acid (25 ml), and the organic layer was washed twice with tap water (5 ml) and concentrated. To the concentrated solution were added potassium thioacetate (1.84 g), dimethylformamide (9 ml) and ethyl acetate (13.5 ml), and the mixture was heated to 65 ± 5 ° C. and stirred for 10 hours. The reaction solution is cooled to 30 ° C. or less, extracted by adding tap water (9 ml) and ethyl acetate (9 ml), the organic layer is washed with 1% sulfuric acid aqueous solution (9 ml) and tap water (9 ml) in this order. Re-extracted with ethyl acetate (4.5 ml). The ethyl acetate layers were combined and concentrated, and toluene (25 ml) was added and concentrated. The obtained slurry was crystallized, filtered and dried to obtain 3.35 g of ATP as crystals (yield: 76.1%).
(Scheme 11)

（実施例１２：アセチルチオスルファミド（ＡＴＳ）の合成法）
ＡＴＰ（１０．０ｇ）にトリフェニルホスフィン（９．０３ｇ）、ＢＳＡ（７．４８ｇ）および酢酸エチル（６０ｍＬ）を加えてスラリー化した後、２０℃以下でジイソプロピルアゾジカルボン酸（ＤＩＡＤ）（６８．３ｇ）／酢酸エチル（１０ｍＬ）を１時間で滴下した。１８〜２１℃で７時間攪拌した後４６．６ｇまで濃縮、イソプロピルアルコール（ＩＰＡ）（５０ｍＬ）を加えて４８．５ｇまで濃縮、再度ＩＰＡ（５０ｍＬ）を加えて４８．２ｇまで濃縮した。再度ＩＰＡ（５０ｍＬ）を加え６６．７ｇまで濃縮した。この溶液を６５℃に加熱し水（７．５ｇ）を加えた後、５０℃で２時間攪拌して晶析、次に５０℃から２５℃まで２．５ 時間かけて徐冷晶析、最後に２５℃で２時間攪拌して結晶をろ過、乾燥してＡＴＳ １１．０５ｇを得た（収率：７３．５％）。

Example 12 Synthesis Method of Acetylthiosulfamide (ATS)
Triphenylphosphine (9.03 g), BSA (7.48 g) and ethyl acetate (60 mL) were added to ATP (10.0 g) to make a slurry, and diisopropyl azodicarboxylic acid (DIAD) (68. 3 g) / ethyl acetate (10 mL) was added dropwise over 1 hour. After stirring at 18 to 21 ° C. for 7 hours, the mixture was concentrated to 46.6 g, isopropyl alcohol (IPA) (50 mL) was added to concentrate to 48.5 g, and IPA (50 mL) was added again to concentrate to 48.2 g. IPA (50 mL) was added again and concentrated to 66.7 g. This solution was heated to 65 ° C., water (7.5 g) was added, and the mixture was stirred at 50 ° C. for 2 hours for crystallization, then slowly cooled from 50 ° C. to 25 ° C. over 2.5 hours, and finally 25 The mixture was stirred at ° C for 2 hours, and the crystals were filtered and dried to obtain 11.05 g of ATS (yield: 73.5%).

  When ATS was synthesized using L-hydroxyproline as a starting material according to Examples 11 and 12, the number of isolations was reduced from 5 to 3 times compared to the cases synthesized according to Examples 2 and 4-6, The number of extractions was reduced from 19 to 4 and the approximate production days were reduced from 536 to 160 days, increasing productivity by 526/160 = 3.3 times.

(Example 13: Synthesis of PNZ-proline (PPR) by direct crystallization method)
Potassium carbonate (18.97 g) was dissolved in water (50 ml) and then ice-cooled. L-hydroxyproline (10.0 g) was added and dissolved therein, and 53% PNZ-Cl toluene solution (31.02 g) Was added dropwise at 2 to 8 ° C, followed by stirring at 2 ° C for 1 hour. After separating the toluene layer from the reaction solution, 15.40 g of 36% hydrochloric acid was added to the aqueous layer, followed by stirring at 10 ° C. for 30 minutes. After confirming crystallization, 4.60 g of 36% hydrochloric acid was added and stirred at 5 ° C. for 1 hour, and then the crystals were filtered and dried to obtain 23.76 g of PPR monohydrate (yield: 94.9%).
(Scheme 12)

（実施例１４：メシルプロリンメチルエステル（ＭＰＲＭ）の合成（直接晶析法））
ＰＰＲ１水和物（１０．００ｇ）をメタノール（５０ｍｌ）に溶解させた後、濃硫酸（５９８ｍｇ）を加えた。６０℃に加温後７時間攪拌した。１０℃以下に冷却してｐＨ約５まで中和した後、１６．６ｇまで濃縮した。酢酸エチル（５０ｍｌ）、１０％ＮａＣｌ（５０ｍｌ）に反応液を加え分液操作により水層を除去後、酢酸エチル層を２０．７ｇまで減圧濃縮した。トルエンに溶媒置換した後、トリエチルアミン（３．７０ｇ）を１０℃以下で加えた。２５℃に温調後、塩化メタンスルホニル（３．８３ｇ）を１０分間で滴下した後、水を加えて晶析後、ろ過、乾燥してＭＰＲＭを結晶として１１．２３ｇ得た（収率９１．６％）。
（スキーム１３）

(Example 14: Synthesis of mesylproline methyl ester (MPRM) (direct crystallization method))
PPR monohydrate (10.00 g) was dissolved in methanol (50 ml), and concentrated sulfuric acid (598 mg) was added. The mixture was stirred at 60 ° C. for 7 hours. After cooling to 10 ° C. or lower and neutralizing to pH about 5, the solution was concentrated to 16.6 g. The reaction mixture was added to ethyl acetate (50 ml) and 10% NaCl (50 ml), the aqueous layer was removed by liquid separation, and the ethyl acetate layer was concentrated under reduced pressure to 20.7 g. After solvent substitution with toluene, triethylamine (3.70 g) was added at 10 ° C. or lower. After adjusting the temperature to 25 ° C., methanesulfonyl chloride (3.83 g) was added dropwise over 10 minutes, and after adding water for crystallization, filtration and drying were performed to obtain 11.23 g of MPRM as crystals (yield 91.%). 6%).
(Scheme 13)

（実施例１５：アセチルチオピロリジン、ＡＴＰ）の合成法（ＭＰＲＭ非単離法）
ＰＰＲ１水和物（１０．００ｇ）をメタノール（５０ｍｌ）に溶解させた後、濃硫酸（５９８ｍｇ）を加えた。６０℃に加温後７時間攪拌した。１０℃以下に冷却してｐＨ約５まで中和した後、１７．８ｇまで濃縮した。酢酸エチル（５０ｍｌ）、１０％ＮａＣｌ（５０ｍｌ）に反応液を加え分液操作により水層を除去後、酢酸エチル層を脱水濃縮した。ＰＮＺ−プロリンメチルエステル（ＰＰＲＭ）酢酸エチル溶液を氷冷した後、塩化メタンスルホニル（３．８３ｇ）、トリエチルアミン（３．７０ｇ）を加えた。反応終了後、酸洗浄、水洗を行い酢酸エチル層を脱水濃縮した。濃縮液（１４．５ｇ）に酢酸エチル（４８ｍｌ）、メタノール（７．５ｍｌ）を加え、氷冷後、ＮａＢＨ₄を３０分間隔で５分割（計２．３１ｇ）して加えた。１時間攪拌後、５％硫酸洗浄、水洗を行い酢酸エチル層を減圧濃縮（１１．８ｇ）した。濃縮液にＤＭＦ（２３ｍｌ）、酢酸エチル（３４ｍｌ）、ＡｃＳＫ（４．５２ｇ）を加え６５℃に加温して７時間熟成した。４０℃以下に冷却後、１％硫酸（２４ｍｌ）を加え減圧濃縮（６０．０ｇまで）を行った。室温に冷却後、１．５時間晶析を行い、ＡＴＰを７．６２ｇ得た。

(Example 15: Synthesis method of acetylthiopyrrolidine, ATP) (MPRM non-isolation method)
PPR monohydrate (10.00 g) was dissolved in methanol (50 ml), and concentrated sulfuric acid (598 mg) was added. The mixture was stirred at 60 ° C. for 7 hours. After cooling to 10 ° C. or lower and neutralizing to pH about 5, the solution was concentrated to 17.8 g. The reaction mixture was added to ethyl acetate (50 ml) and 10% NaCl (50 ml), the aqueous layer was removed by liquid separation, and the ethyl acetate layer was dehydrated and concentrated. After cooling the PNZ-proline methyl ester (PPRM) ethyl acetate solution with ice, methanesulfonyl chloride (3.83 g) and triethylamine (3.70 g) were added. After completion of the reaction, acid washing and water washing were performed, and the ethyl acetate layer was dehydrated and concentrated. Ethyl acetate (48 ml) and methanol (7.5 ml) were added to the concentrated liquid (14.5 g), and after ice cooling, NaBH ₄ was added in 30 divided portions (total 2.31 g). After stirring for 1 hour, 5% sulfuric acid washing and water washing were performed, and the ethyl acetate layer was concentrated under reduced pressure (11.8 g). DMF (23 ml), ethyl acetate (34 ml) and AcSK (4.52 g) were added to the concentrated solution, and the mixture was heated to 65 ° C. and aged for 7 hours. After cooling to 40 ° C. or lower, 1% sulfuric acid (24 ml) was added and concentrated under reduced pressure (up to 60.0 g). After cooling to room temperature, crystallization was performed for 1.5 hours to obtain 7.62 g of ATP.

FIG. 1 is an example of a powder X-ray diffraction analysis diagram of PLM. The upper part shows raw data of powder X-ray diffraction analysis, and the lower part shows the position and size of each peak. The vertical axis represents cps (counts per second, counting rate), and the horizontal axis represents 2θ (diffraction angle). FIG. 2 shows the results of quantifying each peak in the analysis diagram of FIG. FIG. 3 is an example of a powder X-ray diffraction analysis diagram of ATP. The upper part shows raw data of powder X-ray diffraction analysis, and the lower part shows the position and size of each peak. The vertical axis represents cps and the horizontal axis represents 2θ. FIG. 4 shows the results of quantifying each peak in the analysis diagram of FIG. FIG. 5 is an example of an ATS powder X-ray diffraction analysis diagram. The upper part shows raw data of powder X-ray diffraction analysis, and the lower part shows the position and size of each peak. The vertical axis represents cps and the horizontal axis represents 2θ. FIG. 6 shows the results of quantifying each peak in the analysis diagram of FIG. FIG. 7 is an example of a powder X-ray diffraction analysis diagram of TCE isolated by an extraction method. The upper part shows raw data of powder X-ray diffraction analysis, and the lower part shows the position and size of each peak. The vertical axis represents cps and the horizontal axis represents 2θ. FIG. 8 shows the results of quantifying each peak in the analysis diagram of FIG. FIG. 9 is an example of a powder X-ray diffraction analysis diagram of TCE isolated by a direct crystallization method. The upper part shows raw data of powder X-ray diffraction analysis, and the lower part shows the position and size of each peak. The vertical axis represents cps and the horizontal axis represents 2θ. FIG. 10 shows the results of quantifying each peak in the analysis diagram of FIG.

Claims (1)

In the powder X-ray diffraction analysis, the following structure, which shows main peaks at 2θ values of 15.910 ± 0.100, 19.930 ± 0.100 and 25.400 ± 0.100: TCE (4-nitrobenzyl (4R, 5S, 6S) -6-[(1R) -1-hydroxyethyl] -4-methyl-3-[[(3S, 5S) -1- (4-nitrobenzyloxycarbonyl) -5- (sulfur Famoylaminomethyl) pyrrolidin-3-yl] thio] -7-oxo-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylate)

Crystals of the compound.

Images